Real-time pulse of financial headlines curated from 2 premium feeds.
| Details | Saved | Published | Title | Source | Tickers |
|---|---|---|---|---|---|
|
2025-09-29 01:06
2mo ago
|
2025-09-28 19:33
2mo ago
|
Definitive Feasibility Study Begins for 'Stage 1' Production | stocknewsapi |
BGDFF
|
|
|
Targeting Phase 1 commissioning by the end of 2026 HIGHLIGHTS Existing fully permitted Central Gawler Mill adjacent to brownfield Challenger mines Challenger JORC (2012) Mineral Resources Estimate now 313koz Au (10.6Mt @ 0.92 g/t), including 194koz Au (1.87Mt @ 3.23 g/t) in existing open pit and underground mines, where: Challenger Main Open Pit: 70,000oz Au (0.65Mt @ 3.36 g/t Au); Challenger West Open pit: 11,600oz Au (0.03Mt @ 10.7 g/t Au); Challenger Underground (above 215mRL): 89,400oz Au (0.98Mt @ 2.84 g/t Au); and Challenger Deeps (below 90mRL): 23,000oz Au (0.21Mt @ 3.50 g/t Au). Historical tailings storage facility with coarse, higher-grade tailings up to 0.6 - 1.0 g/t Au Evaluating de-risked, two phase transition to operations with initial tailings reprocessing ('Phase 1') followed by the introduction of high-grade (~3 g/t) fresh ore ('Phase 2') Targeting Phase 1 commissioning by end of 2026; credit finance conversations underway ADELAIDE, AU / ACCESS Newswire / September 28, 2025 / Barton Gold Holdings Limited (ASX:BGD)(OTCQB:BGDFF)(FRA:BGD3) (Barton or Company) is pleased to announced that a Definitive Feasibility Study (DFS) has started, targeting 'Stage 1' production utilising the fully permitted Central Gawler Mill (CGM) located at Barton's South Australian Challenger Gold Project (Challenger).
|
|||||
|
2025-09-29 01:06
2mo ago
|
2025-09-28 19:41
2mo ago
|
Is Vistra Stock a Buy Now? | stocknewsapi |
VST
|
|
|
If you believe artificial intelligence will take up a growing share of energy, Vistra might just be the stock for you.
Electricity demand in the U.S. is rising rapidly, primarily driven by data centers and the explosive growth in artificial intelligence. Vistra (VST 2.82%) is one energy company that could benefit from this surge in demand. Vistra raised its outlook, and analysts are turning positive on the stock, but is it a buy today? Let's jump into the business and the investment opportunity it presents. Image source: Getty Images. Vistra's power advantage Vistra serves 5 million residential, commercial, and industrial retail customers, providing them with much-needed electricity. Based in Irving, Texas, Vistra operates a fleet of approximately 41,000 MW of generating capacity, positioning it as the largest competitive power generator in the U.S. It provides power services across 18 states and Washington, D.C., giving it a foothold in all of the major competitive wholesale power markets in the country. The company generates electricity from a diverse portfolio of sources, including: Natural gas: 59% of capacity Nuclear: 16% of capacity and the second-largest nuclear power fleet in the U.S. Coal: 21% of capacity Renewables and battery storage: 4% of capacity Vistra primarily sells power through retail contracts and wholesale markets. In its retail segment, it sells electricity and natural gas to end-use customers, primarily through brands like TXU Energy, Energy Harbor, and Ambit. In its wholesale segment, it sells power, capacity, and ancillary services into all major competitive wholesale markets in the U.S. These markets are managed by Independent System Operators (ISOs) and Regional Transmission Organizations (RTOs), which manage the flow of power to their respective grids. The majority of its generation facilities operate as merchant facilities selling into the spot market or short-term markets. This means that Vistra's profits depend heavily on supply and demand in these regional markets. When prices rise, it can make more money, but when prices fall, earnings will follow. Data centers could provide a tailwind to energy demand Vistra expects load demand to continue growing across its primary markets. One key driver of this growth is the emergence of large data centers that power transformative technologies like artificial intelligence (AI). Numerous hyperscalers have affirmed or increased their capital expenditure levels, providing some visibility into future demand. Energy demand is also picking up thanks to the electrification of oil field operations (especially in the Permian Basin of West Texas) and growth in onshore manufacturing. Management believes load growth will compound annually in a low-to-mid single-digit range through 2030 across its markets, and is expanding its capacity to meet growing demand. The company has secured 20-year license renewals for all six reactors in its fleet, including the recent approval for the Perry Nuclear Power Plant to operate through 2046. It has also started construction on projects supporting contracts with Amazon and Microsoft, with expected commercial operation dates in 2025 and 2026, respectively. Investors should be mindful of this risk Vistra is vulnerable to market fluctuations because it primarily operates as a merchant power provider, making its revenues and operating cash flows significantly affected by volatile prices for wholesale electricity, natural gas, and other fuels. For example, changes in natural gas prices affect operating margins on Vistra's nuclear and coal facilities, as electricity prices generally track natural gas prices. Additionally, if electricity demand does not grow as expected, perhaps due to more energy-efficient AI or slower adoption of AI, its performance could suffer. Is Vistra stock a buy? Vistra stock has surged 78% over the past year, and as a result, it is priced at 34.5 times projected 2025 non-GAAP earnings per share (EPS). Looking forward, analysts project non-GAAP EPS could grow 57% in 2026 to $8.87 and another 17% to $10.35 in 2027. Vistra has favorable tailwinds, especially if data center energy demand ramps up. Strong demand would benefit its merchant power model, enabling it to capitalize on rising demand and energy prices. If you think AI-driven energy demand will continue growing in the next few years, as experts project, Vistra is a stock you'll be glad you own. Courtney Carlsen has positions in Microsoft. The Motley Fool has positions in and recommends Amazon and Microsoft. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-29 01:06
2mo ago
|
2025-09-28 19:50
2mo ago
|
2 No-Brainer Dividend Stocks to Throw $1,000 at Right Now | stocknewsapi |
ABEV
LMT
|
|
|
You don't need super-intelligence to figure out why these two dividend stocks are smart long-term investments.
"The true investor...will do better if he forgets about the stock market and pays attention to his dividend returns." -- Benjamin Graham Many investors follow closely the ups and downs of the stock market, waiting for share price gains. Many investors also overlook another strong source of returns: the dividends many companies dish out to shareholders. If you're browsing for ideas, here are two rock-solid companies with economic moats and a dividend to pay you while you sleep! Flying high When it comes to investments, a pretty good place to start is the U.S. Department of Defense, the largest military budget on planet Earth. It's what has made Lockheed Martin (LMT 0.66%) a bellwether of the defense contracting industry after deriving roughly 75% of its $71 billion in sales last year servicing contracts from the DoD. The great news for long-term investors is that it's a stable source of revenue, as its F-35 contract is the largest defense procurement program ever awarded, and goes through the 2060s. You also won't be shocked to hear that so-called rivals, such as China, Russia, and even hot spots like Iran and North Korea, aren't going away anytime soon. As such, the U.S. defense spending is likely to increase under the Pentagon's focus to modernize the military's ability -- and that's good news for Lockheed Martin investors. F-35A Lightning II Image source: Lockheed Martin. Further, Lockheed sent a memo to investors recently, reminding everyone that it also makes pretty impressive drones, too. Not even a week ago, Lockheed unveiled Vectis, a "lethal collaborative combat aircraft to advance unparalleled air dominance for American and allied militaries." Vectis is a drone designed to work with fighter jets and intended to be a fast-developed, stealthy, and affordable jet. It's a good sign for long-term investors who were concerned Lockheed's business would suffer if drones began replacing manned platforms, such as its lucrative F-35, over the coming decades. Lockheed trades at a price-to-earnings ratio of 27 times, and also offers investors a healthy dividend yield of 2.7%, while investors enjoy the stability of its long-term lucrative F-35 contract as well as its expanding drone business. Big time brewer Ambev (ABEV 0.22%) is the largest brewer in Latin America and the Caribbean, and is Anheuser-Busch InBev's subsidiary in the region; it produces, distributes, and sells beer as well as PepsiCo products in Brazil and other Latin American countries and was formed in 1999 through a merger of Brazil's two largest beverage companies, Brahma and Antarctica. With that history lesson aside, the company has proven it can dominate markets. In fact, Ambev has monopolistic positions across regions that include roughly 60% beer market share in Brazil, 65% in Argentina, El Salvador, and Uruguay, and over 70% in Bolivia, according to Morningstar.com. Here's the upside for investors: Per capita beer consumption across most Latin American countries is lower than typically found in developed countries, which should pave the way for valuable volume growth for Ambev. The company also has a trick up its sleeve because there's been a noticeable trend of consumers opting for foreign beers over domestic ones, which is an opportunity for Ambev to leverage Anheuser-Busch InBev's wide premium portfolio that includes Budweiser, Corona, and Michelob Ultra. It's tough for regional competition to match the scale of Ambev, and the company should be able to maintain its market share through economic cycles while still dishing out its high-yield dividend of 7.6%. Time to buy? Both of these stocks offer investors a healthy dividend, long-term potential, and competitive advantages. The product complexity in Lockheed Martin's defense business helps keep new entrants on the sidelines, while its lengthy F-35 contract gives financial stability and transparency. Ambev has a strong scale advantage over regional peers and plenty of room for growth if developing countries increase their beer consumption and continue reaching for premium import brands. Both stocks can be cornerstones in many portfolios looking for some dividend income. Daniel Miller has no position in any of the stocks mentioned. The Motley Fool recommends Lockheed Martin. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-29 01:06
2mo ago
|
2025-09-28 19:59
2mo ago
|
All It Takes Is $15,000 Invested in Each of These 3 Dow Jones Dividend Stocks to Help Generate Over $1,000 in Passive Income Per Year | stocknewsapi |
KO
PG
SHW
|
|
|
You can count on these ultra-reliable dividend stocks to boost your passive income no matter what the stock market is doing.
As companies mature, they often choose to implement a dividend as a way to directly reward shareholders. On the other hand, smaller up-and-coming companies will want to put all the dry powder possible into their ideas to make them succeed. Coca-Cola (KO -0.52%), Procter & Gamble (PG 0.21%), and Sherwin-Williams (SHW 0.53%) are three industry-leading companies that have been around for over 100 years. Their track records have earned them spots among the 30 components in the Dow Jones Industrial Average (^DJI 0.65%). Dividends have been an integral part of their capital allocation plans for decades. And because all three companies have steadily grown their earnings over time, they have also been able to increase their quarterly dividends. Investing $15,000 into each stock could help you generate over $1,000 in passive dividend income per year. Here's why all three dividend stocks are great buys in October. Image source: Getty Images. This beverage behemoth is also a passive income powerhouse Coca-Cola was one of the few stocks that held up when the market was tanking in response to tariff woes and geopolitical uncertainty in April. That same month, it hit an all-time high. But since then, Coke has been steadily falling while the S&P 500 (^GSPC 0.59%) has been gaining. And after a hot start to the year, Coke is now underperforming the Dow and the S&P 500. ^SPX data by YCharts Coke's fundamentals remain intact. The company is generating solid organic growth and diversifying its beverage lineup by leaning into healthier options. Coca-Cola Zero Sugar and Diet Coke are performing well, and Coke is shifting from high-fructose corn syrup to cane sugar in the U.S. Coke has the beverage lineup, supply chain (through its bottling partnerships), and brand power to adapt to changing consumer preferences. In the meantime, the stock has gotten much cheaper, sporting a 23.6 price-to-earnings (P/E) ratio compared to a 10-year median P/E of 27.7. Coke yields 3.1%, making it a solid source of passive income. And it has raised its dividend for 63 consecutive years, earning it a coveted spot on the list of Dividend Kings. P&G is a great value for long-term investors P&G is in a similar boat to Coke. It has great brands, but consumers are getting hit hard by inflation and cost-of-living pressures. In June, P&G announced plans to cut 7,000 jobs and exit certain brands and markets as part of a restructuring effort. In July, it announced that its chief operating officer, Shailesh Jejurikar, would take over as CEO on Jan. 1, 2026. These major shakeups, paired with relatively weak results and guidance, may be why P&G is hovering around a 52-week low at the time of this writing. P&G has essentially three levers it can pull to grow its earnings. It can sell higher volumes of products, it can raise prices, and it can repurchase stock, which increases earnings per share. Volume growth is the most sustainable option because it has fewer limits compared to price increases, which are subject to consumer constraints. And there's only so much free cash flow P&G generates to buy back its stock (it usually reduces its share count by 1% to 2% per year). Unfortunately, P&G has been relying heavily on price increases in recent years. And consumers are pushing back, as P&G's organic growth has drastically slowed. PG data by YCharts P&G now sports a P/E ratio of 23.4 and a forward P/E of 21.8 compared to a 10-year median P/E of 25.5. Like Coke, P&G is a Dividend King with a high yield at 2.8%. It's a great buy for risk-averse investors looking for a reliable source of passive income who don't mind giving the company time to restructure. Sherwin-Williams' recent pullback is a buying opportunity The paint and coatings giant had been a steady market outperformer to the point where it earned its spot in the Dow last year, replacing commodity chemical giant Dow Inc. But Sherwin-Williams' stock has underperformed the major indexes this year largely due to high interest rates, which are impacting many of its end markets. Sherwin-Williams benefits from increases in consumer spending and economic growth. Higher borrowing costs have been a drag on the housing market and home improvement projects, as evidenced by Home Depot's lackluster earnings growth over the last couple of years. Still, Sherwin-Williams has the makings of an excellent dividend stock for long-term investors. It has 46 consecutive years of dividend raises, but its yield is just 0.9% because the stock price has outpaced its dividend growth rate -- gaining 352% over the last decade, which is even better than the S&P 500's 244% increase. Sherwin-Williams has an excellent business model. It sells its products through its own retail stores, online, and partnerships with retailers like Lowe's Companies. It also has a sizable coatings business and industrial and commercial paints business. Coatings are used to protect surfaces across various industries, including automotive, aerospace, and marine. Add it all up, and Sherwin-Williams is a great buy in October. Quality companies at attractive valuations Coke, P&G, and Sherwin-Williams may not light up a growth investor's radar screen. But all three companies pay growing, ultra-reliable dividends. Coke and P&G have discounted valuations compared to their historical averages, whereas Sherwin-Williams is roughly in line with its 10-year median valuation. Add it all up and these are three picks ideally suited for investors looking to round out their portfolios with non-tech-focused ideas. Daniel Foelber has positions in Procter & Gamble. The Motley Fool has positions in and recommends Home Depot. The Motley Fool recommends Lowe's Companies and Sherwin-Williams. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-29 01:06
2mo ago
|
2025-09-28 20:39
2mo ago
|
Oil slips as Kurdistan crude exports resume, OPEC+ plans output hike | stocknewsapi |
BNO
DBO
GUSH
IEO
OIH
OIL
PXJ
UCO
USO
XOP
|
|
|
A flame rises from a chimney of an oil field in Iraq's Kurdistan region, August 16, 2014. REUTERS/Azad Lashkari/File Photo Purchase Licensing Rights, opens new tab
SummaryKurdistan crude flows to Turkey resumes after 2-1/2 year haltOPEC+ plans another oil output hike in November, sources sayRussia pounds Ukraine in mass drone and missile attackSINGAPORE, Sept 29 (Reuters) - Oil prices slipped nearly 1% on Monday after Iraq's Kurdistan region resumed crude oil exports via Turkey over the weekend and as OPEC+ plans another oil output hike in November, adding to global supplies. Brent crude futures fell 63 cents, or 0.90%, to $69.50 a barrel by 0023 GMT after settling at the highest since July 31 on Friday. U.S. West Texas Intermediate crude was trading at $65.07 a barrel, down 65 cents, or 0.99%, giving back most of Friday's gains. Sign up here. "Ongoing fears of production increase are limiting gains, but a tight near term outlook has crude prices in a vice as the trading week begins," said Michael McCarthy, CEO of investor platform Moomoo Australia and New Zealand. Crude oil flowed on Saturday through a pipeline from the semi-autonomous Kurdistan region in northern Iraq to Turkey for the first time in 2-1/2 years, after an interim deal broke a deadlock, Iraq's oil ministry said. The agreement between Iraq's federal government, the Kurdistan regional government (KRG) and foreign oil producers operating in the region will allow 180,000 to 190,000 barrels per day of crude to flow to Turkey's Ceyhan port, Iraq's oil minister told Kurdish broadcaster Rudaw on Friday. The U.S. had pushed for a restart, which is expected to eventually bring up to 230,000 bpd of crude back to international markets at a time when OPEC+ is boosting output to gain market share. The Organization of the Petroleum Exporting Countries and their allies, or OPEC+, will likely approve another crude production hike of at least 137,000 bpd at its meeting on Sunday, as rising oil prices encourage the group to try to further regain market share, three sources familiar with the talks said. However, OPEC+ has been pumping almost 500,000 bpd less than its targets, defying market expectations of a supply glut. Brent and WTI rose more than 4% last week, their biggest weekly gains since June, as Ukraine's drone attacks on Russia's energy infrastructure cut the country's fuel exports. Russia pounded Kyiv and other parts of Ukraine early on Sunday in one of the most sustained attacks on the capital since the full-scale war began. Reporting by Florence Tan; Editing by Leslie Adler and Jamie Freed Our Standards: The Thomson Reuters Trust Principles., opens new tab |
|||||
|
2025-09-29 01:06
2mo ago
|
2025-09-28 20:39
2mo ago
|
nCino: A Value Stock With A Rebounding Mortgage Business | stocknewsapi |
NCNO
|
|
|
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-09-29 01:06
2mo ago
|
2025-09-28 21:00
2mo ago
|
IXUS: Delayed Tariff Blowback Possible | stocknewsapi |
IXUS
|
|
|
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 18:04
2mo ago
|
Bitcoin Bear Market Warning Signals Trouble for Companies Holding BTC | cryptonews |
BTC
|
|
|
A prominent Bitcoin critic has issued a stark warning to companies holding the cryptocurrency, suggesting they could face a “brutal bear market” as Bitcoin prices drop below critical support levels. The alert comes amid heightened market volatility, raising concerns about the sustainability of business models that rely heavily on holding BTC as a core asset.
|
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 18:06
2mo ago
|
Expect major BTC corrections before new all-time highs: Analyst | cryptonews |
BTC
|
|
|
1 hour ago
Bitcoin will perform like Nvidia and record several major corrections on its path to new all-time highs, analyst Jordi Visser said. 2920 The path to new Bitcoin (BTC) all-time highs will continue to feature major corrections of 20% or more, including possible corrections during Q4, despite it typically being a good quarter for crypto asset prices, according to market analyst Jordi Visser. Visser said Bitcoin is part of the AI trade and compared BTC to Nvidia, a high-performance computer chip manufacturer that has become the world’s most valuable publicly traded company and the first public company to hit a $4 trillion valuation. Visser said: “I just want to remind people that Nvidia is up over 1,000% since ChatGPT’s launch. During that time period, which is less than three years, you've had five corrections of 20% or more in Nvidia before it went back up to all-time highs. Bitcoin's going to do the same thing.”Nvidia’s stock performance shown as price candles, while Bitcoin is displayed as a magenta line. Both have experienced sharp corrections despite the bull market. Source: TradingviewAs artificial intelligence takes over more sectors of the economy and replaces human labor, it will erode traditional companies and make stocks obsolete, driving investors to BTC, which will be the best store of value in the digital age, Visser predicted. The price of Bitcoin is one of the most debated and analyzed topics in crypto, as market analysts attempt to forecast the digital currency’s price trajectory amid a time of rapid technological innovation, market disruption, and fiat currency debasement. Analysts grapple with slow-moving Bitcoin performanceMarket analysts are watching gold and stocks hit new all-time highs while Bitcoin’s price remains near the $110,000 level, down by about 11% from its all-time high of over $123,000. Investors are divided on whether new highs are possible in Q4, catapulting BTC to about $140,000, or if the recent drawdown represents the start of a prolonged bear market that could take BTC’s price down to $60,000. Regulatory hurdles and the lack of progress on a Bitcoin strategic reserve in the United States that grows through periodic market purchases have dampened expectations for some analysts. Previously, some analysts forecast that US government purchases of BTC for a national Bitcoin reserve would be a major price catalyst for the digital asset in 2025. Magazine: Recursive inscriptions: Bitcoin ‘supercomputer’ and BTC DeFi coming soon |
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 18:07
2mo ago
|
Gold vs. Bitcoin: Schiff Criticizes Saylor as Analysts Watch $112K BTC Level | cryptonews |
BTC
|
|
|
Bitcoin’s price trajectory is drawing comparisons to gold’s early 2000s bull run, with analysts pointing to $112,000 as the key breakout level. CoinDesk Senior Analyst James van Straten noted that bitcoin’s market structure is shifting in tandem with gold’s repricing, with steady inflows into spot ETFs creating a stair-step advance. He predicts a slow grind upward, punctuated by healthy 10–20% corrections, much like gold’s long rally two decades ago. While bitcoin may lag gold at times, van Straten expects BTC to outperform on total returns over a full market cycle.
Crypto analyst Michaël van de Poppe highlighted critical near-term price zones. He marked sub-$107,000 as a potential “buy zone,” where dip buyers could reenter the market. On the upside, he flagged $112,000 as the decisive ceiling. A strong daily close above that level would, in his view, confirm renewed momentum and expand risk appetite, often sparking a rotation into major altcoins—what traders call “altcoin mode.” The gold-versus-bitcoin debate was reignited when Euro Capital CEO Peter Schiff criticized Michael Saylor’s bitcoin-heavy corporate treasury strategy. Schiff argued that gold provides far greater liquidity, allowing billions in trades without disturbing the market. In contrast, he claimed, unloading a large bitcoin position could trigger price drops and copycat selling. Bitcoin advocates counter that large exits can be managed over time and through over-the-counter channels, but Schiff emphasized gold’s depth as an advantage for big institutions. From a technical perspective, CoinDesk Research reported bitcoin consolidating between $109,156 and $109,849, with $109,400 emerging as short-term support and $109,750 as resistance. Analysts suggest a close above $109,750 opens the path to $110,000–$111,000, with $112,000 as the broader trigger for upside momentum. A breakdown below $109,400, however, risks a slide toward $109,150 or lower. As of late September, bitcoin remains in a tight $109K–$112K range. A confirmed breakout above $112,000 could set the stage for renewed bullish momentum, while continued sideways movement signals consolidation before the next major move. <Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited> |
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 18:11
2mo ago
|
Bitcoin Treasuries Enter New Era with Strive-Semler Merger | cryptonews |
BTC
|
|
|
The digital asset treasury (DAT) market has reached a turning point after Strive (ASST) announced an all-stock deal to acquire Semler Scientific (SMLR), marking the first-ever merger of two publicly traded bitcoin treasuries. Industry insiders say this move could trigger a wave of consolidation across the sector as companies look for scale, efficiency, and stronger access to capital markets.
The deal is designed to unify bitcoin holdings, boost bitcoin per share, and simplify governance. Once completed, the merged entity will hold nearly 11,000 BTC, supported by Strive’s simultaneous $675 million purchase of 5,885 coins. For Semler, whose stock traded below the value of its bitcoin, the acquisition highlights how non-core businesses may be overshadowed by treasury strategies. Strive CEO Matt Cole emphasized that the transaction is “accretive in bitcoin per share,” aligning with the company’s growth goals and improving capital market access. Industry experts suggest three key paths forward for DATs. First, further DAT-to-DAT mergers, similar to the Strive-Semler deal, will consolidate balance sheets and maximize bitcoin per share. Second, acquiring cash-flowing businesses could help treasuries offset dilution and fund ongoing BTC accumulation. Japan’s Metaplanet, the nation’s largest bitcoin holder, has already outlined plans to acquire profitable companies while exploring financing tools such as perpetual preferred stock, a strategy pioneered by MicroStrategy (MSTR). Finally, industry players are expected to favor direct mergers with established businesses instead of using SPACs, which often bring dilution, redemptions, and regulatory complications. Aligning with legitimate operators provides more stability and investor confidence. The growing maturity of DATs is also reflected in partnerships like FRNT Financial’s recent consulting deal with a digital asset treasury holding $100 million in bitcoin. As consolidation and diversification accelerate, DATs are set to evolve beyond simple BTC holding companies into more complex, growth-driven enterprises, shaping the next era of digital asset treasury strategies. <Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited> |
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 18:13
2mo ago
|
Mike Novogratz Admits Doubts About XRP but Praises Its Strong Community | cryptonews |
XRP
|
|
|
Galaxy Digital CEO Mike Novogratz recently reflected on his changing views of XRP during a discussion with podcaster Kyle Chasse. The well-known investor admitted that he initially believed Ripple’s legal battle with the U.S. Securities and Exchange Commission (SEC) would wipe out the token. However, he now acknowledges XRP’s resilience, crediting Ripple CEO Brad Garlinghouse for navigating the lawsuits while keeping the community strong.
Novogratz emphasized that XRP’s passionate base has been key to its survival. Once dismissive of the token’s “cult-like” following, he now sees such loyalty as an essential part of crypto’s success. According to him, every major cryptocurrency that has thrived owes much of its growth to communities that resemble movements rather than just investors. Unlike traditional equities—where few stocks inspire such devotion beyond rare cases like Tesla—cryptocurrencies thrive on belief-driven ecosystems. He explained that the roots of this phenomenon go back to the 2008 financial crisis, when trust in governments and banks eroded. Crypto communities emerged as a new form of trust, built around decentralization and shared conviction. This, Novogratz noted, is what separates digital assets from conventional investments. Despite once questioning XRP’s decentralization, Novogratz has softened his stance. He admitted that XRP turned out to be one of the best-performing assets since late 2024, defying expectations. “Who would have ever guessed that?” he remarked, pointing out how the token continues to rally despite regulatory pressures. Novogratz also highlighted that the XRP community never sees the asset as “too expensive,” a mindset unusual in traditional markets. With such commitment, he believes XRP has proven that community strength can outweigh skepticism—even from prominent voices like his own. By combining strong leadership, legal perseverance, and unmatched community loyalty, XRP has transformed from a doubtful bet into one of the crypto market’s standout stories. <Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited> |
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 18:16
2mo ago
|
ChinaAMC Launches Tokenized Money Market Fund on Ethereum Amid Regulatory Caution | cryptonews |
ETH
|
|
|
China Asset Management Company (ChinaAMC), one of China’s largest fund managers with over $400 billion in assets under management, has officially entered the tokenization market by launching a blockchain-based money market fund on Ethereum. The new product, called the ChinaAMC USD Digital Money Market Fund Class I USD (CUMIU), is designed to provide stable returns denominated in Hong Kong dollars by investing in short-term deposits and high-quality money market instruments.
Developed through the Libeara tokenization platform, each CUMIU token carries a net asset value of $100 and charges a minimal management fee of just 0.05%, making it one of the most cost-efficient blockchain-based fixed-income products currently available. According to data provider RWA.xyz, the fund has already deployed around $502 million, ranking it as the 11th-largest tokenized fund worldwide. Despite this strong start, it still lags behind major players such as BlackRock’s BUIDL, Ondo’s OUSG, and Franklin Templeton’s BENJI. Interestingly, only two entities currently hold CUMIU tokens, reflecting ChinaAMC’s limited rollout strategy. Analysts suggest that this cautious distribution approach allows the firm to test blockchain infrastructure and ensure compliance before scaling to a wider audience. The selective participation aligns with the regulatory environment in China, where authorities are treading carefully on real-world asset (RWA) tokenization. Reports recently surfaced that Chinese securities regulators asked brokerages in Hong Kong to halt RWA initiatives until stricter asset verification and risk control measures are in place. Even with tighter oversight, the launch underscores the growing momentum of tokenized finance. RWA.xyz reports that over $30 billion worth of tokenized assets are now on-chain, representing a 7% increase in the past month. The number of holders has also grown by 9% to more than 406,000, signaling accelerating investor adoption. ChinaAMC’s entry highlights how tokenization continues to expand globally, even in the face of regulatory caution, cementing blockchain’s role in the future of financial markets. <Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited> |
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 18:19
2mo ago
|
Hyperliquid Launches Hypurr NFTs on HyperEVM Amid Token Volatility | cryptonews |
HYPE
|
|
|
Hyperliquid (HYPE), a leading decentralized exchange (DEX), has introduced a new community-focused initiative with the rollout of its Hypurr NFT collection. The project aims to strengthen user sentiment as the network faces ongoing volatility. A total of 4,600 NFTs were distributed automatically on the HyperEVM, requiring no action from users. According to the Hyper Foundation, 4,313 NFTs went to Genesis Event participants, 144 to the Foundation, and 143 to contributors, including developers and artists. Each NFT reflects unique elements of Hyperliquid’s culture, such as community moods, hobbies, and interests. Notably, CEO Jeff Yan contributed 16 NFTs that were randomly allocated.
The NFTs were minted directly on the HyperEVM, a programmability layer launched in February 2025. This architecture connects smart contracts with Hyperliquid’s Layer-1 via HyperBFT consensus, enabling developers to build applications like lending protocols, vault tokenization platforms, and liquid staking tokens. Alongside the NFT release, Hyperliquid introduced permissionless spot quote assets on its mainnet. This feature allows stable asset deployers to activate quote status under on-chain governance rules. USDH, Hyperliquid’s stablecoin backed by cash and U.S. Treasuries, became the first permissionless quote asset, launching trading pairs like HYPE/USDH. Analysts note that this move positions Hyperliquid to compete more effectively with rivals, including Aster, which has recently overtaken Hyperliquid in trading volumes. Despite these developments, the HYPE token price showed only modest growth, rising 0.8% to $45.61. Market concerns persist due to a looming $12 billion token unlock and recent instability of kHYPE, Hyperliquid’s staked governance token, which briefly lost its peg before recovering. Additionally, security concerns emerged after blockchain investigator ZachXBT reported that attackers stole eight Hypurr NFTs worth around $400,000 from compromised wallets. While Hypurr NFTs highlight Hyperliquid’s commitment to community engagement, ongoing stability challenges—particularly token volatility—remain key hurdles. Still, the combination of NFTs, stablecoin infrastructure, and on-chain innovation underscores Hyperliquid’s determination to expand its ecosystem and reinforce long-term network effects. <Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited> |
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 18:24
2mo ago
|
Aster Price Drops Despite CZ Backing as Traders Rotate to Rivals | cryptonews |
ASTER
|
|
|
Aster (ASTER), the native token powering the decentralized perpetuals exchange launched earlier this September, has faced a sharp correction. In the past 24 hours alone, ASTER slid by 8%, trading at $1.87. This marks a 20% decline from its local high of $2.43 on September 24, fueling debate on whether the project is losing momentum despite its strong start and ties to Binance founder Changpeng Zhao (CZ).
Analysts point to a combination of profit-taking, product concerns, and shifting sentiment as drivers of the sell-off. Investor Mike Ess disclosed on X (Twitter) that he sold 60% of his ASTER holdings in favor of Bitcoin (BTC) and Plasma (XPL), citing doubts about Aster’s platform. Comparing it to rival Hyperliquid’s HYPE token, Ess said Aster “feels slower, less polished, and copy-paste,” adding that larger allocations felt riskier. Similar views have been echoed by other traders. Prominent analyst Clemente fully exited ASTER, stating Hyperliquid dominates in most performance metrics. This highlights intensifying competition in the perpetual DEX market, where speed, trust, and user experience heavily influence adoption. CZ’s involvement has also sent mixed signals. While his firm YZi Labs (formerly Binance Labs) holds a stake in Aster, recent comments sounded more cautious, with CZ framing Aster as “complementary” to the broader BNB Chain ecosystem. Some traders interpreted this as distancing, raising concerns about long-term commitment from the Binance founder. Despite the negative sentiment, Aster’s fundamentals remain impressive. The platform has already generated over $82 million in fees and reached $701 million in total value locked (TVL) on BNB Chain—a strong feat for a project only weeks old. Still, the quick pullback underscores the challenges of maintaining user trust while scaling rapidly. With rival Hyperliquid pushing ahead, Aster’s future will depend on whether its team can improve product reliability and sustain momentum. For now, opinions remain divided: some see Aster as an overhyped experiment, while others view it as a high-potential DEX with CZ’s stamp of approval. <Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited> |
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 18:26
2mo ago
|
Bitcoin and Ethereum ETFs Face $1.7B Outflows as Market Volatility Grows | cryptonews |
BTC
ETH
|
|
|
Spot Bitcoin and Ethereum exchange-traded funds (ETFs) in the United States saw a sharp reversal last week, recording over $1.7 billion in net outflows. The downturn came as both cryptocurrencies endured price declines of more than 8% during the reporting period, sparking a wave of redemptions from institutional investors.
According to data from SoSoValue, spot Bitcoin ETFs lost $903 million in net withdrawals. This marked the end of a month-long streak of inflows that had previously reflected growing institutional demand for Bitcoin exposure. However, sentiment shifted as global economic uncertainty deepened, prompting investors to trim risk and adopt a more defensive stance. Ethereum ETFs faced even steeper challenges. The nine US-listed spot Ethereum ETFs recorded $796 million in redemptions, the largest weekly outflow since their launch earlier this year. The synchronized retreat highlights a broader cooling in crypto ETF demand, as market participants reassess strategies in light of macroeconomic headwinds. The sell-off was driven by concerns over persistent inflation, slowing global growth, and uncertainty around US monetary policy, factors that have reduced appetite for high-risk assets like cryptocurrencies. As a result, many institutional allocators who once viewed spot crypto ETFs as an accessible entry point are now scaling back exposure. At the same time, newly launched ETFs tied to Solana and XRP have started to attract fresh investor interest. These products are drawing capital away from traditional Bitcoin and Ethereum funds, signaling a shift toward diversification within digital asset portfolios. While risk sentiment has cooled, demand for crypto exposure remains selective, with investors exploring opportunities beyond the two largest cryptocurrencies. Meanwhile, CryptoQuant data suggests that Bitcoin treasury firms raising capital through PIPE deals are facing additional pressure as share prices move toward discounted issuance levels, underscoring broader stress in crypto capital markets. In the current climate, Bitcoin and Ethereum remain central to digital asset investing, but growing competition from alternative token ETFs reflects an evolving landscape where investors are cautious, defensive, yet still open to diversification opportunities. <Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited> |
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 18:29
2mo ago
|
Cardano Upgrades Could Drive ADA Toward $3 by 2027 | cryptonews |
ADA
|
|
|
Cardano’s native token ADA faces a decisive few years as major upgrades like Project Acropolis, Hydra adoption, and Ouroboros Leios roll out. These milestones may reshape Cardano’s technical narrative, with potential to push ADA closer to the long-awaited $3 mark by 2027. This analysis is based solely on network upgrades and their adoption impact—it excludes external factors like ETFs, regulation, or institutional entry.
Project Acropolis, expected between late 2025 and early 2026, focuses on modular node re-architecture. By improving stability, easing stake pool operations, and enabling faster shipping of features, it reduces execution risk. If successful, ADA could trade between $0.70 and $0.95, with market sentiment hinging on consistent release cadence and operator feedback. Hydra, Cardano’s layer-2 scaling solution, is set for broader adoption in 2026. Its value lies not in version updates but in integration by leading dApps. If users experience real gains in speed and cost reduction, ADA could move between $0.90 and $1.40. Without clear adoption, however, prices may stagnate under $1. Ouroboros Leios, targeted for testnet release in mid-to-late 2026, introduces parallelism at the base layer. Strong performance metrics could reposition Cardano as a high-capacity, decentralized chain, supporting ADA in the $1.30–$2.20 range. Weak testnet results or delays would limit gains near $1.20. Beyond 2027, Cardano’s “Mega” scaling roadmap could compound these advances, lifting ADA to $2–$3.50—provided upgrades deliver visible user benefits and security holds. Each step builds on the previous: Acropolis enables faster releases, Hydra drives adoption, and Leios strengthens scalability. Ultimately, execution—not promises—will determine whether ADA breaks its multi-year ceiling. Consistent delivery, live dApp adoption, and transparent governance are the key signals investors should watch. <Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited> |
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 19:28
2mo ago
|
XRP's September 2025 Catalysts: Why the Token Could Be a Turning Point for Investors | cryptonews |
XRP
|
|
|
In September 2025, XRP has emerged as one of the most closely watched digital assets in the crypto market. A combination of regulatory clarity, institutional inflows, and technological upgrades to the XRP Ledger (XRPL) is creating an environment that could define the token's trajectory for the rest of the year.
|
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 19:30
2mo ago
|
Shareholders Approve Kimono-Maker Marusho Hotta's ‘Bitcoin Japan' Rebrand | cryptonews |
BTC
|
|
|
The Japanese kimono and textiles maker Marusho Hotta is set to confirm it will change its name to Bitcoin Japan.
|
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 19:30
2mo ago
|
Whales Scoop $1.73B In Ether As Exchange Balances Hit Nine-Year Low | cryptonews |
ETH
|
|
|
Reports have disclosed that 16 wallets picked up 431,018 Ether between September 25 and 27, spending about $1.73 billion to do so. The buys came through names like Kraken, Galaxy Digital, BitGo, FalconX and OKX.
That scale of accumulation pushed attention back to who is buying the dip, and why larger players seem willing to add exposure while prices wobble. Exchange Balances Fall To 9-Year Low According to Glassnode data, the amount of ETH held on exchanges has plunged from roughly 31 million to about 14.8 million ETH — a drop of 52% from 2016 levels. Many of those coins are likely in staking contracts, cold wallets or institutional custody, and the recent launch of the first Ethereum staking ETF has helped pull more supply off exchanges. Lower exchange balances mean fewer coins ready to be sold instantly on exchanges, which can make price moves sharper when big orders hit the market. ETH Hovers Near $4,000 As Volatility Rises Based on TradingView readings, ETH is trading around $4,011, down roughly 0.33% over the last 24 hours and more than 10% over the past week. ETHUSD currently trading at $4,015. Chart: TradingView The token briefly slipped under $3,980 earlier in the session before climbing back, and it remains below a recent close of $4,034. This two-week pullback has returned ETH to a key $4,000 support area, and short-term swings have become more pronounced as holders reposition. $3,700 Becomes A Line In Sand Crypto analyst Ted Pillows has warned that the $3,700 to $3,800 zone could face heavy pressure. Reports note that if ETH falls below $3,700, many margin positions could be wiped out and spark forced selling that pushes prices lower. $ETH liquidity heatmap is showing decent long liquidations around the $3,700-$3,800 level. This level could be revisited again before Ethereum shows any recovery. pic.twitter.com/SQTbfrujAa — Ted (@TedPillows) September 27, 2025 With fewer coins on exchanges and concentrated margin exposure, the short-term outlook is more fragile even as longer-term demand indicators look solid. ETF Outflows Show Institutional Mood Can Flip US-listed ETH funds recorded nearly $800 million in outflows this week, their largest redemptions to date. Still, roughly $26 billion sits in Ethereum ETFs, equal to 5.37% of total supply. Whales keep accumulating $ETH! 16 wallets have received 431,018 $ETH($1.73B) from #Kraken, #GalaxyDigital, #BitGo, #FalconX and #OKX in the past 3 days.https://t.co/0DPxgZMGN7 https://t.co/xtPLBKo9LZ pic.twitter.com/oEXZKIErmr — Lookonchain (@lookonchain) September 27, 2025 Those numbers underline how quickly institutional sentiment can change: big inflows can vanish just as fast, and ETF flows now add a new, sizable layer to price dynamics. Lookonchain data also highlighted a prior accumulation of roughly $204 million in ETH, showing similar patterns of large players stepping up during dips. Retail traders appear more cautious for now. But the sequence of big buys from institutional-grade custodians suggests some buyers view dips as buying chances while others choose to wait on the sidelines. Featured image from Unsplash, chart from TradingView |
|||||
|
2025-09-29 00:06
2mo ago
|
2025-09-28 19:45
2mo ago
|
Pi Network's Big Event Reaches Halfway Point: Key Updates for Pioneers | cryptonews |
PI
|
|
|
The optional midpoint check-in took place last week.
|
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 15:00
2mo ago
|
Should You Buy BigBear.ai Stock Right Now? | stocknewsapi |
BBAI
|
|
|
The stock has rocketed 361% over the last 12 months.
BigBear.ai (BBAI -5.74%) is a leader in providing artificial intelligence (AI) technology for national security. Investor optimism about increasing government investment in AI, and the potential impact on BigBear, has sent the stock up 361% over the last year. President Donald Trump's "big, beautiful bill" could be a catalyst, as it provides substantial funding for spending on defense technology. BigBear.ai believes it is well positioned to benefit, but does this make the stock a buy? Image source: Getty Images. BigBear.ai is aiming for large government deals Revenue has been flat over the last three years. The company reported an 18% year-over-year decrease in revenue in the second quarter, driven by lower volume from certain Army programs. While the loss of revenue from these Army programs was a setback, legislative tailwinds are in BigBear's favor. The bill provides billions of dollars in funding for border security, which is one of BigBear's specialties, where it supplies biometric solutions for traveler processing. BigBear ended last quarter in a solid financial position. It has a net cash position of $248 million on its balance sheet -- the strongest financial position in the company's history. Management intends to invest aggressively in hiring top-tier AI talent and innovation to win a share of the funding going to national security programs. The stock offers significant upside potential from a market cap of just $2.6 billion. But the company will have to prove it is up to the job and win more contracts, which is no guarantee. I would look at the stock like a call option on whether the company can land a big contract. This is a stock for those who are willing to accept high volatility for the potential of explosive returns if BigBear.ai can secure large government deals. John Ballard has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 15:28
2mo ago
|
NGG Investor News: If You Have Suffered Losses in National Grid plc (NYSE: NGG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights | stocknewsapi |
NGG
|
|
|
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of National Grid plc (NYSE: NGG) resulting from allegations that National Grid plc may have issued materially misleading business information to the investing public. SO WHAT: If you purchased National Grid securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=41344 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. WHAT IS THIS ABOUT: On July 2, 2025, Reuters published an article entitled “‘Preventable’ National Grid failures led to Heathrow fire, findings say.” The article stated that a “fire that shut London’s Heathrow airport in March, stranding thousands of people, was caused by the UK power grid’s failure to maintain an electricity substation, an official report said on Wednesday, prompting the energy watchdog to open a probe.” Further, the article stated that the United Kingdom’s Energy minister, Ed Miliband, had “called the report “deeply concerning”, after it concluded that the issue which caused the fire was identified seven years ago but went unaddressed by power grid operator National Grid[.]” On this news, National Grid’s American Depositary Shares (“ADSs”) fell 5%, on July 2, 2024. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] www.rosenlegal.com |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 15:43
2mo ago
|
SNPS Investor News: If You Have Suffered Losses in Synopsys, Inc. (NASDAQ: SNPS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights | stocknewsapi |
SNPS
|
|
|
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Synopsys, Inc. (NASDAQ: SNPS) resulting from allegations that Synopsys may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Synopsys securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=44981 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. WHAT IS THIS ABOUT: On September 9, 2025, after market hours, Synopsys issued a press release entitled “Synopsys Posts Financial Results for Third Quarter Fiscal Year 2025.” In this announcement, Synopsys’ CEO was quoted as saying that “[w]hile I’m proud of how our team navigated external challenges in the quarter, our IP business underperformed expectations. We are taking action to enhance our competitive advantage and drive resilient, long-term growth.” The next day, Zacks Equity Research published an article entitled “Synopsys Q3 Earnings and Revenues Miss Estimates, Stock Plunges 22%.” The article stated that Synopsys shares had “plunged” after it “reported results for the third quarter of fiscal 2025, missing both top and bottom-line consensus estimates.” On this news, the price of Synopsys stock fell $216.59 per share, or 35.8%, to close at $387.78 on September 10, 2025. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] www.rosenlegal.com |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 16:00
2mo ago
|
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer | stocknewsapi |
VCYT
|
|
|
Findings from the first prospective validation trial for biomarker presented at ASTRO 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, announced that new data from the prospective, randomized integral biomarker BALANCE trial (NCT03371719) finds that the PAM50 molecular signature predicts which patients with recurrent prostate cancer benefit from hormone therapy with apalutamide in addition to salvage radiation therapy. The prostate PAM50 biomarker is currently available for Research Use Only on the Decipher GRID (Genomic Resource for Intelligent Discovery) research tool. This is an unprecedented advancement for patients who can be more-precisely selected to receive hormone therapy or forego the treatment and the potential side effects. Share The new findings were shared today by Daniel Spratt, M.D., University Hospitals Seidman Cancer Center, Case Western Reserve University, in a podium presentation at ASTRO 2025, the annual meeting of the American Society for Radiation Oncology, being held in San Francisco. “Our findings mark the first time, to my knowledge, that a predictive biomarker has been validated in a prospective, biomarker-driven, randomized trial in non-metastatic prostate cancer,” said Dr. Spratt. “Thus, this is an unprecedented advancement for patients who can be more-precisely selected to receive hormone therapy or forego the treatment and the potential side effects.” For the study, 295 men with recurrent, non-metastatic prostate cancer following prostate-removal surgery were randomly assigned to salvage radiation therapy with a placebo or apalutamide for 6 months. The PAM50 biomarker was a key stratification variable to ensure each arm had a similar proportion of luminal B and non-luminal B subtypes. They were followed for a median of 5 years during which they were evaluated for biochemical failure, which is a rise in levels of prostate-specific antigen (PSA) post treatment—an early sign of salvage therapy failure. Among the 127 men with luminal B molecular subtype tumors (as determined by the PAM50 signature), 72% of those taking apalutamide did not experience biochemical failure, as compared to the 54% rate in the placebo group [HR 0.45 (80% CI 0.29-0.68), p=0.0062]. In the non-luminal B subset, there was no difference between those taking apalutamide versus placebo (70% vs 71%) [HR 0.95 (80% CI 0.65-1.41), p=0.44]. “These results from NRG GU006 represent the highest level of evidence to support routine biomarker testing in recurrent prostate cancer patients planned to receive secondary radiotherapy,” Dr. Spratt added. “With such a strong difference in the metastasis-free survival response to hormone therapy between luminal B and non-luminal-B tumors, the use of the predictive PAM50 biomarker is a game changer to help personalize treatment for men with recurrent prostate cancer beyond merely prognostic tools.” The PAM50 signature is the third biomarker—assessed through the whole-transcriptome-based Decipher platform—that a major study has shown predicts benefit from hormone therapy, radiation therapy or chemotherapy. Another trial—PREDICT-RT—recently completed enrollment two years early and is evaluating the Decipher Prostate test’s ability to predict benefit of combined hormone therapy (ADT and apalutamide) concurrent with radiation in patients with high-risk prostate cancer at initial diagnosis. “Prostate cancer, like all cancers, is a disease of the genome,” said Elai Davicioni, Ph.D., Veracyte’s medical director for Urology. “Our Decipher GRID tool uniquely enables researchers to better pinpoint adverse molecular features that are associated with poor outcomes. This can ultimately lead to more-personalized care for each patient based on their tumor’s unique molecular make-up. We are proud to partner with the world’s leading prostate cancer researchers to help uncover insights that can change the trajectory of care for each individual patient and also help deliver the next generation of prostate cancer diagnostics.” The BALANCE trial results are among 9 Decipher-focused abstracts being presented at the ASTRO 2025 conference. More information can be found here. About Decipher Prostate The Decipher Prostate Genomic Classifier is a 22-gene test, developed using RNA whole-transcriptome analysis and machine learning, that helps inform treatment decisions for patients across the full spectrum of prostate cancer. The test is performed on biopsy or surgically resected samples and conveys the aggressiveness of the cancer. For patients with localized or regional prostate cancer, the Decipher score indicates a patient's risk of metastasis, helping to determine treatment timing and intensity. For patients with metastatic prostate cancer, the Decipher score indicates the likelihood of cancer progression and survival benefit with treatment intensification. Armed with this information, physicians can better personalize their patients’ care. The Decipher Prostate test's performance and clinical utility has been demonstrated in over 90 studies involving more than 200,000 patients. It is the only gene expression test to achieve “Level I” evidence status and inclusion in the risk-stratification table in the most recent NCCN® Guidelines* for prostate cancer. More information about the Decipher Prostate test can be found here. About Veracyte Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit www.veracyte.com or follow us on LinkedIn or X (Twitter). About Decipher GRID The Decipher GRID database includes more than 250,000 whole-transcriptome profiles from patients with urologic cancers and is used by Veracyte and its partners to contribute to continued research and help advance understanding of prostate and other urologic cancers. GRID-derived information is available on a Research Use Only basis. More information about Decipher GRID can be found here. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements, including, but not limited to our statements regarding the use of the predictive PAM50 biomarker to help personalize treatment for men with recurrent prostate cancer beyond merely prognostic tools and the belief that this is a game changer, and expectations that our Decipher GRID tool uniquely enables researchers to better pinpoint adverse molecular features that are associated with poor outcomes; that this can ultimately lead to more-personalized care for each patient based on their tumor’s unique molecular make-up; and that this can help uncover insights that can change the trajectory of care for each individual patient and also help deliver the next generation of prostate cancer diagnostics. Forward-looking statements can be identified by words such as: “appears,” “anticipate,” “intend,” “plan,” “expect,” “believe,” “should,” “may,” “will,” “enable,” “positioned,” “offers,” “designed,” "ultimately," and similar references to future periods. Actual results may differ materially from those projected or suggested in any forward-looking statements. These statements involve risks and uncertainties, which could cause actual results to differ materially from our predictions, and include, but are not limited to the potential impact the Veracyte Diagnostics Platform can have on scientific advancements in cancer and, in turn, patient care. Additional factors that may impact these forward-looking statements can be found under the caption “Risk Factors” in our Annual Report on Form 10-K filed on February 28, 2025. Copies of these documents, when available, may be found in the Investors section of our website at https://investor.veracyte.com. These forward-looking statements speak only as of the date hereof and, except as required by law, we specifically disclaim any obligation to update these forward-looking statements or reasons why actual results might differ, whether as a result of new information, future events or otherwise. Veracyte, the Veracyte logo, and Decipher are registered trademarks of Veracyte, Inc., and its subsidiaries in the U.S. and selected countries. * National Comprehensive Cancer Network. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. More News From Veracyte, Inc. |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 16:00
2mo ago
|
SINA Investors Have Opportunity to Lead Sina Corporation Securities Fraud Lawsuit | stocknewsapi |
SINA
|
|
|
, /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of sellers of ordinary shares, including those that sold into the Merger of Sina Corporation (NASDAQ: SINA) between October 13, 2020 and March 22, 2021, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. So What: If you sold Sina ordinary shares, including those that sold into the Merger, during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Sina class action, go to https://rosenlegal.com/submit-form/?case_id=45219mailto:or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the Case: According to the lawsuit, defendants' created a fraudulent scheme to depress the value of Sina ordinary shares to avoid paying a fair price to Sina's shareholders in connection with the Merger. Defendants executed this scheme by misrepresenting and/or omitting material information within and from Sina's proxy materials in connection with the Merger that were necessary for shareholders to make an informed decision concerning whether to vote in favor of the Merger. Specifically, defendants failed to disclose that: (1) defendants concealed the true value of Sina's investment in TuSimple at the time of the Merger; (2) in turn, the offer of $43.30 per ordinary share as consideration for the Merger substantially shortchanged the true value of Sina ordinary shares; and (3) as a result, defendants' statements about Sina's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Sina class action, go to https://rosenlegal.com/submit-form/?case_id=45219 mailto:call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] www.rosenlegal.com SOURCE THE ROSEN LAW FIRM, P. A. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 16:00
2mo ago
|
ROSEN, A LEADING NATIONAL FIRM, Encourages Fortinet, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FTNT | stocknewsapi |
FTNT
|
|
|
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Fortinet, Inc. (NASDAQ: FTNT) common stock between November 8, 2024 and August 6, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 21, 2025.
SO WHAT: If you purchased Fortinet common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Fortinet class action, go to https://rosenlegal.com/submit-form/?case_id=45210 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 21, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants made materially false and misleading statements concerning the business impact and sustainability of a purportedly “record” round of FortiGate unit upgrades. Defendants represented that this “refresh cycle” was “by far the largest we’ve seen probably ever,” would generate “around $400 million to $450 million in product revenue” in 2025 and 2026, and would create strong opportunities to cross-sell additional products and services. Defendants also represented that the refresh cycle would “gain momentum” in the second half of 2025 and beyond. The lawsuit alleges these statements were materially false and misleading. In truth, defendants knew that the refresh cycle would never be as lucrative as they represented because it consisted of old products that were a “small percentage” of the Company’s business. Moreover, defendants misrepresented and concealed that they did not have a clear picture of the true number of FortiGate firewalls that could be upgraded. And while telling investors that the refresh would gain momentum over the course of two years, Fortinet misrepresented and concealed that it had aggressively pushed through roughly half of the refresh in a period of just a few months, by the end of 2Q 2025. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Fortinet class action, go to https://rosenlegal.com/submit-form/?case_id=45210 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] www.rosenlegal.com |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 16:51
2mo ago
|
PTX Metals Inc. Announces Private Placement Amendments | stocknewsapi |
PANXF
|
|
|
September 28, 2025 4:51 PM EDT | Source: PTX Metals Inc.
Toronto, Ontario--(Newsfile Corp. - September 28, 2025) - PTX Metals Inc. (TSXV: PTX) ("PTX" or the "Company") is pleased to announce the following updates to its previously disclosed non-brokered private placements, as referenced in its news releases dated September 8, 2025 and September 16, 2025. In response to market demand, the Company has increased the maximum size of the offering (the "LIFE Offering") being completed under LIFE Exemption (as defined below) from $3,500,000 to $5,500,000 while keeping a minimum offering of $2,000,000 of HD Units (as defined below). There remains no minimum on the size of the offering of "charity flow-through units" ("CFT Units"). LIFE Offering Pursuant to the amended terms of the LIFE Offering, the Company is offering for sale by way of non-brokered private placement: (i) hard dollar units (the "HD Units") at a price of $0.10 per HD Unit; and (ii) CFT Units at a price of $0.15 per CFT Unit (the CFT Units together with the HD Units are referred to herein as, the "Units"), to raise aggregate gross proceeds of up to $5,500,000. Each Unit shall consist of one (1) common share and one-half of one (1/2) share purchase warrant (each whole such share purchase warrant, a "Warrant"). Each Warrant is exercisable to acquire one (1) additional Warrant Share at a price of $0.16 per Warrant Share for a period of 36 months from the date of issuance. The Warrants issued pursuant to the LIFE Offering will be subject to a restriction on exercise expiring 61 days following the date of issuance. The Company intends to use the proceeds from the issuance of the HD Units for general corporate expenses and working capital purposes. The gross proceeds from the issuance of the CFT Units will be used to incur eligible "Canadian exploration expenses" as defined in subsection 66.1(6) of the Income Tax Act (Canada) (the "Tax Act") that qualify as "flow-through critical mineral mining expenditures" as defined in subsection 127(9) of the Tax Act (the "Qualifying Expenditures") related to the Company's projects in Ontario. The Qualifying Expenditures will be incurred on or before December 31, 2026 and will be renounced by the Company to the initial purchasers of the CFT Units with an effective date no later than December 31, 2025 in an aggregate amount not less than the gross proceeds raised from the issue of the CFT Units. The Units issued under the LIFE Offering are being offered to purchasers pursuant to the Listed Issuer Financing Exemption (the "LIFE Exemption") under Part 5A of National Instrument 45-106 - Prospectus Exemptions, and as modified by Coordinated Blanket Order 45-935 - Exemptions from Certain Conditions of the Listed Issuer Financing Exemption, in each of the provinces of Canada. Pursuant to the LIFE Exemption, the Units to be issued pursuant to the LIFE Offering will not be subject to a hold period under Canadian securities laws. The Company has filed on its SEDAR+ profile contemporaneously herewith an amended and restated offering document addressing the upsized LIFE Offering available for purchase in accordance with the requirements of Form 45-106F19 (the "Offering Document"). The amended and restated Offering Document can be accessed under the Company's profile at www.sedarplus.ca and on the Company's website at www.ptxmetals.com. Prospective investors should read the amended and restated Offering Document before making an investment decision. Non-LIFE Offering In addition, the previously disclosed concurrent non-brokered offering (the "Non-LIFE Offering") has also been amended. The amendments remove the charity flow-through component of this offering and increase the maximum size of the offering of flow-through units ("FT Units") from $1,000,000 to $1,500,000. The FT Units will be issued at a price of $0.135 per FT Unit with each FT Unit being comprised of one common share and one-half of one (1/2) Warrant. The securities sold under the Non-LIFE Offering will be sold under prospectus exemptions other than the LIFE Exemption and the securities underlying the FT Units sold under the Non-LIFE Offering will be subject to a hold period of four months and one day from the date of issuance. The closing of the LIFE Offering and Non-LIFE Offering (the "Closing") may occur in multiple tranches, with the final Closing expected to occur starting on September 29, 2025. The offerings are subject to certain conditions, including applicable regulatory approvals and acceptance by the TSX Venture Exchange ("TSXV"). Additional Information Insiders of the Company may participate in the offerings. The issuance of securities to insiders will be considered "related party transactions" within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company intends to rely on the exemption set forth in section 5.5(a) of MI 61-101 from the formal valuation requirements of MI 61-101 and the exemption set forth in section 5.7(1)(a) of MI 61-101 from minority shareholder approval requirements of MI 61-101 in respect of such insider participation as the fair market value of the offerings, insofar as they involve interested parties, is not expected exceed 25% of the Company's market capitalization. In connection with the offerings (as permitted by the policies of the TSXV), eligible finders will be paid a cash amount equal to 7% of the gross amount raised by finders. In addition, a number of finder warrants equal to 7% of the number of Units and FT Units issued pursuant to the offerings (the "Finders Warrants") will be issued to eligible finders. Each Finders Warrant will entitle the holder thereof to purchase one common share at a price of $0.14 (subject to adjustment) for a period of two (2) years following the issuance of the Finders Warrants. The Finders Warrants will be subject to a statutory hold period in Canada of four (4) months and one (1) day after the issuance of the Finders Warrants. About PTX Metals Inc. PTX is a mineral exploration company focused on high-quality strategic metals assets in northern Ontario, allowing exposure for shareholders to Copper, Gold, Nickel, and PGEs discovery. The Province of Ontario is renowned as a first-class mining jurisdiction for its abundance of mineral resources and safe jurisdiction. Our corporate objective is to advance our assets, and unveil the potential of two Flagship Projects, the W2 Cu-Ni-PGE located in the strategic Ring of Fire region, and the Shining Tree Gold Project neighbor to multi-million ounces gold deposits in the Timmins Gold Camp. PTX's portfolio of assets was strategically acquired for their geologically favorable attributes, and proximity to established mining companies. PTX is based in Toronto, Canada. The Company is also listed in Frankfurt under the symbol "9PF" and on the OTCQB in the United States as "PANXF". For additional information on PTX, please visit the Company's website at www.ptxmetals.com. Cautionary Statement Regarding Forward-Looking Information This news release includes forward-looking information and statements. Such statements include statements relating to the ability to complete the offerings, the timing of Closing, the extent of insider participation, and the use of proceeds of the offerings. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. The assumptions on which the forward-looking statements contained herein rely include, among others, that the Company will receive the necessary approvals for the offerings from the TSXV, that the Company will satisfy the terms of the LIFE Exemption and any other applicable securities exemptions or safe harbors and that there will be sufficient demand for the securities. Additional risk factors that may impact the Company or cause actual results and performance to differ from the forward looking statements contained herein are set forth in the Company's most recent management's discussion and analysis of financial condition (a copy of which can be obtained under the Company's profile on SEDAR + at www.sedarplus.ca). Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws. NEITHER THE TSXV, NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN TSXV POLICY 1.1 - INTERPRETATION) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. NO STOCK EXCHANGE, SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE INFORMATION CONTAINED HEREIN. NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. THIS NEWS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY OF THE SECURITIES IN THE UNITED STATES. THE SECURITIES HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "U.S. SECURITIES ACT") OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED UNDER THE U.S. SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE. THIS NEWS RELEASE DOES NOT CONSTITUTE AN OFFER OR SALE OF SECURITIES IN THE UNITED STATES. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268290 |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 17:00
2mo ago
|
Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich's Ataxia | stocknewsapi |
LRMR
|
|
|
Conference call and webcast on Monday, September 29, 2025 at 8:00 am EDT
September 28, 2025 17:00 ET | Source: Larimar Therapeutics BALA CYNWYD, Pa., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host a conference call and webcast to discuss updates for the Company’s nomlabofusp clinical development program including data from the ongoing long-term open label study for the treatment of Friedreich’s ataxia on Monday, September 29, 2025 at 8:00 am EDT. Conference Call and Webcast Details To access the webcast on Monday, September 29, 2025 at 8:00 am EDT, please visit this link to the event. To participate by phone, please dial 1-877-407-9716 (domestic) or 1-201-493-6779 (international) and refer to conference ID 13756144 or click on this link and request a return call. Following the live event, an archived webcast will be available on the “Events & Presentations” page of the Larimar website. About Larimar Therapeutics Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. Larimar’s lead compound, nomlabofusp, is being developed as a potential treatment for Friedreich's ataxia. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com. Forward-Looking Statements This press release contains forward-looking statements that are based on Larimar’s management’s beliefs and assumptions and on information currently available to management. All statements contained in this release other than statements of historical fact are forward-looking statements, including but not limited to statements regarding Larimar’s ability to develop and commercialize nomlabofusp and any other planned product candidates, Larimar’s planned research and development efforts, including the timing of its nomlabofusp clinical trials, interactions and filings with the FDA, expectations regarding potential for accelerated approval or accelerated access and time to market and overall development plans and other matters regarding Larimar’s business strategies, ability to raise capital, use of capital, results of operations and financial position, and plans and objectives for future operations. In some cases, you can identify forward-looking statements by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks, uncertainties and other factors include, among others, the success, cost and timing of Larimar’s product development activities, nonclinical studies and clinical trials, including nomlabofusp clinical milestones and continued interactions with the FDA; that preliminary clinical trial results may differ from final clinical trial results, that earlier non-clinical and clinical data and testing of nomlabofusp may not be predictive of the results or success of later clinical trials, and assessments; that the FDA may not ultimately agree with Larimar’s nomlabofusp development strategy; the potential impact of public health crises on Larimar’s future clinical trials, manufacturing, regulatory, nonclinical study timelines and operations, and general economic conditions; Larimar’s ability and the ability of third-party manufacturers Larimar engages, to optimize and scale nomlabofusp’s manufacturing process; Larimar’s ability to obtain regulatory approvals for nomlabofusp and future product candidates; Larimar’s ability to develop sales and marketing capabilities, whether alone or with potential future collaborators, and to successfully commercialize any approved product candidates; Larimar’s ability to raise the necessary capital to conduct its product development activities; and other risks described in the filings made by Larimar with the Securities and Exchange Commission (SEC), including but not limited to Larimar’s periodic reports, including the annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, filed with or furnished to the SEC and available at www.sec.gov. These forward-looking statements are based on a combination of facts and factors currently known by Larimar and its projections of the future, about which it cannot be certain. As a result, the forward-looking statements may not prove to be accurate. The forward-looking statements in this press release represent Larimar’s management’s views only as of the date hereof. Larimar undertakes no obligation to update any forward-looking statements for any reason, except as required by law. Investor Contact: Joyce Allaire LifeSci Advisors [email protected] (212) 915-2569 Company Contact: Michael Celano Chief Financial Officer [email protected] (484) 414-2715 |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 17:10
2mo ago
|
Should Disney Drop Broadcasting ABC To Avoid Government Meddling? | stocknewsapi |
DIS
|
|
|
(Photo by Beata Zawrzel/NurPhoto via Getty Images)
NurPhoto via Getty Images Tucked amid the outcry over Jimmy Kimmel’s suspension, FCC threats against broadcast licensees, and all the rest, a modest analyst proposal surfaced that would short circuit the possibility of a future repeat of the mess. What if Disney stopped broadcasting, asked Needham Securities analysts Laura Martin and Dan Medina in a Sept. 23 research note? Don’t dismantle the network, just put all the news, sports, entertainment and more on Disney streaming service Hulu, where all of its FX shows run, and on the ABC app. That way, the next time FCC Chairman Brendan Carr threatens licenses over his upset about a comedian’s bad joke, or station groups decide to pre-empt programming, Disney could continue reaching its audiences and advertisers. The key: don’t sell the broadcast licenses when you stop broadcasting, because that puts the FCC back in position to commit political mischief, because it must approve license transfers. “We calculate that shutting down (not selling) ABC would force (Disney) to write off about $1.7 (billion) to $2.7 (billion) of free spectrum value, plus about $1.4 (billion) of lost (free cash flow) per year, which is worth about $8.3 (billion) of value based on current TV trading comps,” Martin wrote. That sounds like a fair amount of money, but Martin and Medina suggest, “Value destruction would be (as) low as a percent of (Disney’s $204 billion) market (capitalization), and (one-time) only, which Wall Street would add back." MORE FOR YOU And ABC, despite its top-rated evening news and hits such as Abbott Elementary, isn’t driving a lot of viewership overall. Nielsen estimates the network is averaging only 2.4 million viewers in prime time across broadcast and cable. Martin and Medina estimated the network and its owned & operated local stations generate only about $4 billion in revenues, down 11% from 2024. Dumping the fading broadcast platform for streaming and online delivery would allow Disney investors to better value the company’s faster-growing sectors, expanding valuation multiples by 40 to 60 basis points per year for the next decade, Martin and Medina wrote. That would add 10% more value for Disney shareholders. The real issue driving Needham’s proposal: studios can’t afford to screw around with political headaches and grandstanding at a moment when the entire business is being radically transformed by generative artificial intelligence. "GenAI collapses time frames, thereby making the delays, distractions and headaches of regulation more expensive, so jettisoning regulatory risks is increasingly valuable,” the Needham analysts wrote. As with just about any way-out-of-the-(TV)-box idea, there are some big caveats. Though broadcast ratings continue to decline, they remain the best way to reach a large, broadly based audience. That’s particularly important to the major sports leagues who provide some of TV’s most valuable programming. They depend on broadcast to reach casual fans, relying on subscription services to extract more income from hard-core followers. The NBA’s rich new contracts signed last summer were decided in part by the fact that Disney had ABC and ESPN and its streaming operations. Comcast’s NBCUniversal bid was also considered superior because of its broadcast component, compared to long-time league partner Warner Bros. Discovery, which only has a cable network and streaming. Amazon, the third winning bid, is, well, Amazon. Similarly, CNBC reported last week that the NFL wants to advance its “look-in” provisions by a year for $111 billion in TV contracts. After more recent big rights renewals for the NBA, college football, and other leagues, the creators of television’s most-watched programming are concerned they may have left money on the table when they signed those original NFL deals. Will having a broadcast operation still be required of any traditional media partner going forward as the league tries to anticipate what will matter in the media ecosystem of the early 2030s? Another potential complication for such a bold move: Carr and influential FCC staffers have rumbled about expanding the commission’s regulatory power far beyond broadcast, where government regulation is said to be necessary because it relies on divvying up scarce publicly owned broadcast spectrum. But getting into areas such as regulating online cable-like operators such as YouTube TV, or more broadly tweaking the Communication Act’s Section 230 safe-harbor provisions protecting online services are a different thing altogether. Those kinds of regulatory extensions would require a deeply divided Congress to get on board. That could be difficult, especially given that even some conservatives said they were deeply dismayed by Carr’s comments around the Kimmel controversy. Beyond all these issues, there is one of history and sentiment. ABC and Disney have been connected since the 1950s, when Leonard Goldenson needed programming for his new American Broadcasting Corporation. But the movie studios largely wouldn’t countenance letting even their old movies run on television, with one exception. Walt Disney’s family-owned studio had lots of animated features and shorts and nature documentaries sitting largely unused in its library. And Walt needed money to finance his ambitious plans for a Disney theme park in Anaheim. Out of that shared set of interests came The Wonderful World of Disney (among many other names), which would anchor Sunday prime-time schedules for ABC and then other networks for decades. Fast forward to the 1990s. Walt is gone, Michael Eisner is CEO, charged with transforming the studio into a bigger media company. Among his deals: the $19 billion acquisition in 1996 of Capital Cities/ABC, whose senior TV executives included an ambitious former weatherman named Robert Iger. Iger spent 22 years with ABC before the Disney deal, and now has run Disney as CEO for close to that long across two stints. Iger’s been a fierce guardian of the Disney brand, but he’s not known as a sentimentalist. Given his ABC roots, though, would Iger ever countenance a dramatic move like Martin and Medina suggest? Probably not. But there is another consideration. The Disney board is expected to name Iger’s successor over the next few months, and the clubhouse favorite has long been co-head of entertainment Dana Walden. Walden, a frequent walking partner with Iger, is also a long-time friend of former Vice President Kamala Harris, whose mere name seems to enrage Trump. Would a move out of Brandon Carr-regulated broadcasting take away one of the ways the administration might monkey with a preferred successor, or any major moves she might undertake at CEO? Again, probably not. But the bigger question, as Martin and Medina lay it out, is how well Hollywood’s battered media companies can navigate a fast-changing ecosystem where YouTube attracts more streaming eyeballs than anyone, AI is dramatically reducing the cost of production and marketing, politically motivated regulators are seeking even more power, and dirt-cheap micro dramas out of China are grabbing more and more attention. Bold moves may be just what’s needed. |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 17:27
2mo ago
|
United Therapeutics Corporation - Special Call | stocknewsapi |
UTHR
|
|
|
United Therapeutics Corporation - Special Call
Company Participants Harrison Silvers - Manager of Investor Relations Leigh Peterson - Executive Vice President of Product Development & Xenotransplantation Martine Rothblatt - Founder, Chairman & CEO Conference Call Participants Steven D. Nathan Olivia Brayer - Cantor Fitzgerald & Co., Research Division Andreas Argyrides - Oppenheimer & Co. Inc., Research Division Joseph Thome - TD Cowen, Research Division Lisa Walter - RBC Capital Markets, Research Division Jessica Fye - JPMorgan Chase & Co, Research Division Jason Gerberry - BofA Securities, Research Division Presentation Operator Good afternoon, and welcome to the United Therapeutics Corporation Phase 3 TETON-2 Results Conference Call. My name is Drew, and I will be your conference operator today. [Operator Instructions] Please note that this call is being recorded. I would now like to turn the webcast over to Harry Silvers, Investor Relations Manager at United Therapeutics. Harrison Silvers Manager of Investor Relations Thank you, Drew. Good day, everyone. It is my pleasure to welcome you to the United Therapeutics Corporation Phase 3 TETON-2 results conference call. Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events. These statements involve risks and uncertainties that may cause actual results to differ materially. Our latest SEC filings, including Forms 10-K and 10-Q, contain additional information on these risks and uncertainties. We assume no obligation to update forward-looking statements. Today's remarks may discuss the progress and results of clinical trials or other developments with respect to our products. These remarks are intended solely to educate investors and are not intended to serve as the basis for medical decision-making or to suggest that any products are safe and effective for any unapproved or investigational uses. Full prescribing information for the products is available on our website. Accompanying me on today's call are Dr. Steve Nathan, Schar Chair of the Advanced Recommended For You |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 17:47
2mo ago
|
Silo Wellness Submits CSE Listing Statement for Review of Born Defense Proposed Change of Business | stocknewsapi |
SILFF
|
|
|
September 28, 2025 5:47 PM EDT | Source: Silo Wellness Inc.
Eugene, Oregon and Toronto, Ontario--(Newsfile Corp. - September 28, 2025) - Silo Wellness Inc. (CSE: SILO) ("Silo" or the "Company"), to be renamed Born Defense Inc., is pleased to announce that it has submitted its listing statement (the "Listing Statement") with the Canadian Securities Exchange (the "CSE") on September 26, 2025, for review in connection with its previously announced proposed change of business to an investment issuer focused on the defense and national security sectors. The Listing Statement provides comprehensive disclosure regarding the Company's business, assets, financial statements, management team, and strategic direction, and is a key step toward satisfying the CSE's requirements for the resumption of trading of the Company's common shares. As previously disclosed, the Company intends to complete a name change to Born Defense Inc. and transition its primary business focus to defense innovation and national-security investments. Born's strategy is grounded in Just War principles and the protection of individual liberty, a framework discussed at length in the Compony's podcast interview with Dr. Eric Patterson, a leading scholar of the Just War tradition ("Just War Doctrine with Dr. Eric Patterson," https://youtu.be/pBkZG9mZDMk). In that conversation, Dr. Patterson emphasized the classical criteria (legitimate authority, right intention, last resort, probability of success, proportionality, and discrimination) and how those ethics constrain power, guide deterrence, and inform responsible industrial stewardship. The submission of the Listing Statement is an important milestone in advancing this vision. The Listing Statement also outlines recent measures undertaken by the Company to strengthen its financial position, including agreements to settle approximately CAD $4.4 million of debt through the issuance of common shares, significantly reducing liabilities and positioning the Company for its strategic transition. Upon CSE approval, this restructuring is expected to improve the balance sheet and align shareholder interests as the Company advances its change of business. "While this must go through the full regulatory process, I'm proud of how hard our team has worked to stabilize and strengthen the public vehicle by earning buy-in from creditors who have either agreed to convert their debt into shares or to middle- and long-term payment plans so initial financing can stretch further. I'm looking forward to feedback from the CSE on our business plan and intentions. Until then, we'll prepare for the future with a steadfast goal of peace through strength. Now is the time to preserve civilization through strategic investment in the people trusted to responsibly steward these powerful defense technologies for the next generations." — Richard Craven, CEO, Born Defense The Listing Statement will be made available on the Company's profile on SEDAR+ once it has been accepted for filing by the CSE. Shareholders will also be provided with notice of any meeting required to approve the proposed change of business and related matters, in accordance with applicable securities laws and stock exchange requirements. There can be no assurance as to the timing of completion of the CSE's review process, the Company's shareholder approval, or the resumption of trading of the Company's securities. About Born Defense Silo Wellness (CSE: SILO) is a public company currently transitioning its operations into Born Defense Inc., a national security investment issuer committed to ethical defense finance guided by the Just War Doctrine. The company's restructured business model centers on trade finance, strategic equity investments, and collateral-backed lending for pre-IPO and critical infrastructure ventures globally. Follow and amplify: LinkedIn: www.linkedin.com/company/borndefense X/Twitter: www.x.com/borndefense Instagram: www.instagram.com/borndefense YouTube: www.youtube.com/@borndefenseTelegram Investor Updates: https://t.me/BornDefense Telegram Discussion Group: https://t.me/+q4c0eGS3gD8wNzIx Forward-Looking Statements This press release contains forward-looking statements under applicable securities laws. These statements relate to future events, financial performance, and operational expectations, including the objectives, prospective transaction, market conditions, and strategic plans. Forward-looking statements involve risks, uncertainties, and assumptions that may cause actual results to differ materially, including market conditions, regulatory changes, geopolitical factors, capital availability, and the timing and outcome of the CSE's review of the Listing Statement. We undertake no obligation to update these statements except as required by law. Readers should not place undue reliance on forward-looking statements, which speak only as of their date. No Offer or Solicitation This press release is for informational purposes only and does not constitute an offer or solicitation to buy or sell securities. Any such offering will be made only in compliance with applicable laws and through authorized offering documents. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268286 |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 17:59
2mo ago
|
Palantir Technologies Announces Two-Day Pop-Up Experience in Seoul | stocknewsapi |
PLTR
|
|
|
-
Two-day showcase in Seoul celebrates Korean fanbase with limited-edition company merchandise drops. DENVER--(BUSINESS WIRE)--Palantir Technologies will open a two-day pop-up merchandise store in Seoul's culturally dynamic Seongdong-gu district from October 14-15, marking the company's first dedicated retail experience for its passionate Korean fanbase. The temporary store at 26 Achasan-ro 11ga-gil in Seongdong-gu will showcase six items—five being sold publicly for the first time. Merchandise will be available in limited quantities on a first-come, first-served basis. Store hours run from 12:00 to 8:00 PM KST on Tuesday and Wednesday, October 14-15. Store Information: Location: 26 Achasan-ro 11ga-gil, Seongdong-gu, Seoul, South Korea Public Hours: Tuesday-Wednesday, October 14-15, 12:00 to 8:00 PM KST About Palantir's Korean Community South Korea represents one of Palantir's most enthusiastic international fanbases, with our community understanding what's required when geopolitical realities demand technological superiority. Since relaunching our external merchandise platform in June 2025, Korean customers have emerged as our second-largest international market. The pop-up serves as both a celebration and expansion of this organic community support, featuring partnerships with leading Korean companies to create an immersive experience for our fans to recognize mission-critical technology when it matters most. The Seoul pop-up reinforces Palantir's commitment to showing up where it matters—engaging directly with communities that appreciate what we build. We've always believed the best way to serve our community is by working alongside them, not from corporate headquarters. Strategic Location in Seoul's Emerging Cultural Hotspot Seongdong-gu was chosen for its reputation as Seoul's emerging cultural hotspot—a former industrial area now packed with artisanal cafes, independent boutiques, and creative co-working spaces. The district's proximity to Seoul Forest and excellent subway connectivity ensures accessibility from across the metropolitan area. Software that dominates. Additional information is available at https://www.palantir.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir’s expectations regarding the amount and the terms of the contract and the expected benefits of our software platforms. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include our ability to meet the unique needs of our customers; the failure of our platforms to satisfy our customers or perform as desired; the frequency or severity of any software and implementation errors; our platforms’ reliability; and our customers’ ability to modify or terminate their contract. Additional information regarding these and other risks and uncertainties is included in the filings we make with the Securities and Exchange Commission from time to time. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise. More News From Palantir Technologies Inc. Back to Newsroom |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 18:00
2mo ago
|
Is Axon Enterprise Stock's Valuation Justified? | stocknewsapi |
AXON
|
|
|
Axon has been a big winner on the market, but its high valuation may give some investors pause.
You might not know it, but Axon Enterprise (AXON -0.30%) is one of the best-performing stocks of the last decade. The maker of TASER electrical stun guns, body cameras, and related software is up more than 3,000% during that period. The company has built a vast network of products and services across law enforcement technology, establishing itself, with the help of some acquisitions, as the clear leader in that niche but growing industry. The surge in Axon's price during that period hasn't come exclusively from growth in the business. As the chart below shows, the stock's earnings per share has grown by about 1,000% over the last decade, meaning its valuation has tripled. Data by YCharts. As its earnings multiple has expanded, the stock has gotten expensive. These days, the stock trades at a price-to-earnings ratio of 110. Is the stock overvalued, or is its valuation justified? Let's take a closer look at where Axon stands today to answer the question. Image source: Axon. A one-of-a-kind business Axon's mission is to protect life and make the bullet obsolete. Over its history, that's expanded from its TASER less-than-lethal weapons to body cameras for recording police interactions and software that helps law enforcement agencies manage records, evidence, and other data. Like Apple, Axon has created a hardware and software ecosystem with the two components complementing each other. Its body and dashboard cameras, for instance, generate footage that's stored with its cloud service. The company has even introduced a new generative AI offering, Draft One, that can create first drafts of police reports based on bodycam footage. The company's ecosystem has driven strong growth over its history, solid profits, and an increasingly wide economic moat. In its second quarter, revenue rose 33% to $669 million, its sixth consecutive quarter with growth above 30%. Gains were balanced across both the software and services and connected devices segments. It reported adjusted net income of $174 million. On a generally accepted accounting principles (GAAP) basis, net income was $36 million. The company continues to update its core product portfolio with the TASER 10 and Axon Body 4 representing the latest versions of its hardware. It has also introduced new products and services, such as VR training and drone-as-first-responder systems. Most recently, management announced the acquisition of Prepared, an AI-powered emergency communications platform. Prepared's technology helps turn 911 calls into actionable intelligence, enabling a faster response from emergency responders. Prepared is the type of company that fits well under the Axon umbrella as the company can fold it into the larger product portfolio to make its platform more attractive to law enforcement agencies. Does the valuation make sense? Axon reported a GAAP operating loss of $9.8 million through the first half of 2025 as the company undergoes an investment cycle in new technologies like AI, but software companies tend to earn a lofty earnings multiple if they can demonstrate growth and an adjusted profit. One major line item the company excludes from its adjusted profit metrics is share-based compensation, which totaled $279 million year to date, or roughly 22% of revenue. Axon's outstanding share count has increased nearly 25% in just the past five years, though that hasn't been enough of a problem to deter its soaring share price. With a triple-digit price-to-earnings ratio, investors should recognize the reduced margin of safety from such a valuation. But while Axon stock may be pricey, even after falling 20% from its all-time high, it remains fairly valued given its unique business model and strong track record. Jeremy Bowman has positions in Axon Enterprise. The Motley Fool has positions in and recommends Apple and Axon Enterprise. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 18:00
2mo ago
|
The 5 Best S&P 500 Stocks of the Last 10 Years | stocknewsapi |
AMD
ANET
AVGO
AXON
NVDA
|
|
|
Led by Nvidia, the best stocks over the last decade include three other stocks driven by the buildout of AI infrastructure -- AMD, Arista, and Broadcom -- and one defense stock, Axon.
Short-term stock performance gets a lot of financial press, but much of it is meaningless noise. Long-term investors should consider a stock's long-term performance -- and its current growth prospects -- when making stock investing decisions. A company's strong stock performance over the longer term, particularly in technology and other fast-evolving spaces, oftentimes reflects an agile and capable top management team and a winning business model. With that said, below are the five best-performing stocks on the S&P 500 index over the last decade through Friday, Sept. 26. If you're a growth stock investor, they are all worth considering buying, especially Nvidia. Image source: Getty Images. Best-performing stocks over the last 10 years Stocks are listed in order of descending 10-year performance. Company Market Cap Forward P/E Wall Street's Estimated Annualized 5-Year EPS Growth YTD 2025 Return 10-Year Return Nvidia (NVDA 0.27%) $4.3 trillion 39.5 34.9% 32.7% 31,161% Advanced Micro Devices (AMD -1.05%) $259.0 billion 27.1 30.9% 32.0% 9,225% Arista Networks (ANET -0.36%) $179.0 billion 43.5 20.6% 28.9% 3,489% Broadcom (AVGO -0.48%) $1.6 trillion 36.5 34.0% 45.3% 3,356% Axon Enterprise (AXON -0.30%) $55.7 billion 84.0 18.4% 19.3% 2,906% S&P 500 Index -- -- -- 14.1% 310% Data sources: Yahoo! Finance, finviz, and YCharts. P/E = price-to-earnings ratio. EPS = earnings per share. YTD = year to date. Data to Sept. 26, 2025. 1. Nvidia: 31,161% return over a decade Nvidia's graphics processing units (GPUs) are considered the gold standard for training artificial intelligence (AI) models and deploying AI applications. As such, the company's revenue and earnings growth have exploded upward since the advent of generative AI about three years ago. Generative AI has greatly expanded the potential use cases for AI. In its fiscal second quarter, Nvidia's revenue soared 56% year over year to $46.7 billion. Growth was driven by a 56% surge in AI-driven data center revenue to $41.1 billion, which was 88% of total revenue. The data center sells GPUs and other compute products, along with high-performance networking products. The gaming, professional visualization, and auto platforms grew revenue 49%, 32%, and 69%, respectively. The quarter's adjusted net income jumped 52% to $25.8 billion, translating to a 54% leap in earnings per share (EPS) to $1.05. These fantastic results were achieved despite Nvidia not selling any H20 data center AI chips to China because the U.S. government's export controls spanned the entire quarter. 2. Advanced Micro Devices (AMD): 9,225% return over a decade AMD competes with Nvidia in the discrete GPU market. It trails Nvidia considerably in the AI-driven data center GPU market -- which it just entered a couple of years ago -- and trails Nvidia moderately in the gaming GPU market. Along with GPUs, AMD also makes central processing units (CPUs), with Intel being its major competitor. In its second quarter, AMD's revenue grew 32% year over year to $7.69 billion. By segment, revenue growth was data center, 14% to $3.2 billion; client, 67% to $2.5 billion; gaming, 73% to $1.1 billion; and embedded, negative 4% to $824 million. Data center growth was significantly hurt by AMD being unable to sell AI-enabling MI308 GPUs to China due to the U.S. export controls. For context, in the first quarter, data center revenue jumped 57% year over year. Moreover, AMD's profit was also hurt by the export controls, as it took inventory and related charges of about $800 million. Its adjusted net income was $781 million, with EPS of $0.48, down 30% year over year. The China situation and AMD's scaling up of its data center GPU business, which currently sports a lower profit margin than its more established overall business, will likely weigh on the company's earnings growth for some time. That said, with demand for GPUs so powerful and the wait for Nvidia's GPUs sometimes extended, AMD's longer-term picture looks bright. 3. Arista Networks: 3,489% return over a decade Arista is a leader in cloud networking solutions for large data centers and enterprise campuses. Specifically, it sells hardware, including high-performance Ethernet switches and routers, and software for monitoring and control of the network. The rapid adoption of AI is boosting demand for Arista's products. In the second quarter, Arista's revenue increased 30% year over year to $2.2 billion. Product revenue grew 32% to $1.9 billion, and software and service revenue rose 23% to $328 million. Adjusted net income jumped 37% to $923.5 million, translating to EPS rising 38% to $0.73. 4. Broadcom: 3,356% return over a decade Broadcom makes semiconductors and infrastructure software. Its strong recent growth is being driven by robust demand for its products for AI data centers, including custom AI chips and Ethernet networking products, and its November 2024 acquisition of software maker VMware. The custom AI chips are application-specific integrated circuits (ASICs) for large tech companies that have designed their own AI chips. These are for internal use and, in some cases, for availability in their cloud computing services. In its fiscal third quarter (ended Aug. 3), Broadcom's revenue grew 22% to $16.0 billion. AI-related revenue is growing like gangbusters. In the quarter, it grew 63% year over year to $5.2 billion, accounting for 33% of revenue. Adjusted net income surged 37% year over year to $8.4 billion, which translated to EPS rising 36% to $1.69. 5. Axon Enterprise: 2,906% return over a decade Axon develops weapons and related technology products for the law enforcement, military, and consumer markets. The company makes Tasers, which are electroshock weapons that incapacitate the target; body-worn cameras; and other hardware and software products. In the second quarter, Axon's revenue grew 33% year over year to $669 million, of which $292 million was recurring software and services revenue. Growth was driven by strong adoption of premium software and robust demand for Taser 10, Axon Body 4 body camera, and counter-drone equipment. Adjusted net income soared 83% year over year to $174 million, translating to EPS surging 74% to $2.12. Beth McKenna has positions in Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Arista Networks, Axon Enterprise, Intel, and Nvidia. The Motley Fool recommends Broadcom and recommends the following options: short November 2025 $21 puts on Intel. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 18:00
2mo ago
|
SLQT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages SelectQuote, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SLQT | stocknewsapi |
SLQT
|
|
|
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the “Class Period”), of the important October 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased SelectQuote securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the SelectQuote class action, go to https://rosenlegal.com/submit-form/?case_id=39510 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 10, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) SelectQuote was directing Medicare beneficiaries to the plans offered by insurers that best compensated SelectQuote, regardless of the quality or suitability of the insurers’ plans; (2) SelectQuote did not provided unbiased comparison shopping for Medicare Advantage insurance plans; (3) SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers and limit enrollment in competitors’ plans; (4) as a result, SelectQuote had not complied with applicable laws, regulations, and contractual provisions; (5) SelectQuote was vulnerable to regulatory and legal sanctions as a result of its conduct, including claims that it had violated the False Claims Act; and (6) as a result of the foregoing, defendants’ positive statements about SelectQuote’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the SelectQuote class action, go to https://rosenlegal.com/submit-form/?case_id=39510 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. _______________________ Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] www.rosenlegal.com |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 18:15
2mo ago
|
Why Johnson & Johnson Could Be the Ultimate Dividend King | stocknewsapi |
JNJ
|
|
|
Johnson & Johnson has increased its dividend every year for 63 consecutive years. It doesn't want to stop.
Some stocks simply pay a regular dividend. The smarter ones also raise their dividend payout every year, putting more cash in their shareholders' pockets. The ultimate ones have been raising their dividends for several decades and are committed to continuing. Johnson & Johnson (JNJ 1.12%) falls in the third bracket. Johnson & Johnson, or J&J, is a Dividend King. That's an elite group of publicly listed companies in the U.S. that have increased their dividends for at least 50 consecutive years. This past April, J&J raised its dividend for the 63rd consecutive year. Can you expect J&J to continue paying a bigger dividend year after year? Absolutely. J&J has a massive portfolio, a huge pipeline, and a solid cash profile. Image source: Getty Images. After spinning off its consumer health business (brands like Tylenol, Neutrogena, and Listerine) into a separate publicly listed company called Kenvue, J&J has become a healthcare pure play with a focus on pharmaceuticals and medical technology. Between the two verticals, 26 products or platforms generate over $1 billion in sales each, and that largely drives its revenue and cash flows. J&J generates a lot of cash to plow back into growth and research and development (R&D), and pays dividends from the rest. In 2024, it spent $17 billion on R&D and paid out $11.8 billion in dividends. Within its innovative medicines segment, J&J aspires to become the leading oncology company with $50 billion in sales. Darzalex and Carvykti should drive the push. Recently acquired Intra-Cellular Therapies for $14.6 billion has also added antipsychotic drug Caplyta to J&J's portfolio, a product it expects to scale to $5 billion. On the medtech side, robotic surgery and cardiovascular are major growth engines. J&J is one of the largest healthcare companies in the U.S. today. Its rare mix of size, disciplined R&D investment, steady cash generation, a humongous pipeline, and six decades of uninterrupted dividend hikes makes it a solid contender for the ultimate dividend stock. The stock yields 2.9%. Neha Chamaria has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Kenvue. The Motley Fool recommends Johnson & Johnson and recommends the following options: long January 2026 $13 calls on Kenvue. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 18:16
2mo ago
|
Is This a Red Flag for Tesla's Upcoming Q3 Deliveries Update? | stocknewsapi |
TSLA
|
|
|
Fresh Europe data on August Tesla registrations wasn't pretty.
Tesla (TSLA 3.94%) shares fell more than 4% last Thursday as investors digested disappointing Tesla vehicle registration data in Europe ahead of the company's third-quarter deliveries update expected in early October. The electric vehicle maker sells premium battery-electric cars and energy storage products globally, with meaningful exposure to the European market. The market's question now is simple: Does the regional weakness point to a poor quarter, or is it mostly noise inside a broader and still-uncertain recovery? Image source: Getty Images. The latest Europe read was weak News out Thursday showed Tesla's European Union registrations fell about 37% year over year in August to roughly 8,200 vehicles, marking a second straight month in which the China-based BYD outsold Tesla in the bloc. Including the broader European region (the U.K., Norway, and other EFTA countries), Tesla still led in absolute units for August, but registrations were down about 22% year over year, underscoring persistent pressure in the region. This softness in Europe follows a tough second quarter for the electric car maker. In Q2, Tesla delivered just over 384,000 vehicles -- down 13% from about 444,000 in the year-ago period. It is also worth recalling the company's tone on the latest earnings call. CEO Elon Musk acknowledged that the near term may not be smooth, noting that things could get "rough" before they get better over the next few quarters. While that comment doesn't guarantee weak third-quarter deliveries, it frames Tesla's headlines about European deliveries within management's own caution about the path back to growth. Setting expectations for Q3 With only days left in the period when the August Europe data hit the tape, the right way to think about Q3 is probably through a conservative range, not a single-point guess. Start with what we know: Tesla delivered about 384,000 vehicles in the second quarter, it delivered roughly 463,000 in last year's third quarter, and outside Europe there are mixed but not universally negative signals. Some trackers have flagged improving weekly registrations in parts of Europe late in September, and several outlooks have pointed to steadier demand in China and the U.S., even as Europe stays choppy. Still, Europe's August decline argues for caution. A reasonable, conservative estimate for Q3 deliveries is 430,000 to 455,000. The low end assumes Europe remains a drag through quarter-end and that China/U.S. improvement only partly offsets it. The high end assumes late-September sequential gains in key markets and typical quarter-end logistics help. That range sits close to widely cited expectations near the mid-440,000s and acknowledges both the seasonal lift from Q2 and the regional weakness that surfaced this week. For reference, landing near 445,000 would be down modestly year over year versus the roughly 463,000 delivered in last year's third quarter. Of course, in the end, no one knows where deliveries will come from. Further, note that this is a conservative estimate. There's always a chance that deliveries could come in above this range (or even below). Meanwhile, the stock's valuation doesn't help the bull case. At a market value well above $1 trillion and with a price-to-earnings ratio of 252 as of this writing, the stock embeds high expectations well beyond one quarter's deliveries. Such a high valuation leaves less cushion if third-quarter deliveries disappoint, or if commentary points to rough demand trends going into year-end. Of course, there are some significant positives for investors to consider, too. Energy storage deployments remain a bright spot. Furthermore, a recent Model Y refresh, advancements in self-driving technology, and a planned upcoming vehicle launch could all contribute to increased demand in the second half of the year. But given this fresh data on Tesla registrations in the E.U., it's fair to say that risk sits a bit higher heading into next week's update. The bigger story, anyway, will be a forward-looking one. Investors should look for any insight management provides on how quickly it thinks deliveries can reaccelerate. Because sales are going to need to pick up sharply at some point in order for Tesla's fundamentals to live up to its stock price. Daniel Sparks and/or his clients have positions in Tesla. The Motley Fool has positions in and recommends Tesla. The Motley Fool recommends BYD Company. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 18:33
2mo ago
|
2 No-Brainer Dividend Stocks With Yields Above 5% You Can Buy Now and Hold at Least a Decade | stocknewsapi |
DOC
O
|
|
|
Investors who buy these high-yield stocks now can look forward to steadily rising dividend payments in the years to come.
Successful dividend investors know that simply chasing the highest yields can lead to disaster. By finding companies that can sustain and grow their payouts through various market cycles, everyday investors can confidently assemble a portfolio that produces a steadily growing stream of passive income. Right now, Reality Income (O 0.83%) and Healthpeak Properties (DOC 2.29%) are perfect examples of companies well positioned to raise their dividend payouts regardless of what happens to the overall economy. Image source: Getty Images. You won't have to wait around before they start delivering a significant amount of income to your brokerage account. Both stocks offer yields above 5% at recent prices. 1. Realty Income Individual investors looking for a steadily growing stream of passive income have gotten their wish from Realty Income. Since going public in 1994, this real estate investment trust (REIT) has raised its dividend payout 132 times, or nearly every quarter. At recent prices, the stock offers a huge 5.4% dividend yield that it delivers in convenient monthly payments. Each payout bump is relatively small, but they add up over time. Realty Income's payout has risen by 46% over the past 10 years. Realty Income doesn't operate the buildings it owns. It gets tenants to sign net leases that transfer all the variable costs associated with building ownership, such as taxes and insurance, to the tenant. This leads to such reliable cash flows that the REIT boasts an A3 credit rating from Moody's. With its enviable credit rating, Realty Income can offer businesses a relatively inexpensive source of capital through sale-leaseback transactions. Despite already having 15,606 buildings in its portfolio, there's still plenty of room for this real estate investment trust to keep growing. In the U.S., publicly traded net lease REITs like Realty Income account for 4% of their addressable market. This figure is just 0.1% in Europe. With an occupancy rate of 98.6% at the end of June, Realty Income expects adjusted funds from operations (FFO), a proxy for earnings used to evaluate REITs, to land in a range between $4.24 and $4.28 per share this year. This is plenty more than it needs to meet a dividend payout currently set at $3.234 per share. With a well-funded payout and plenty of room to grow, adding this stock to a diversified portfolio is the right move for most income seeking investors. 2. Healthpeak Properties If there's one thing income-seeking investors hate, it's a dividend reduction. Healthpeak is a specialized net lease REIT that caters to biotech start-ups, big pharmaceutical companies, and everything in between. Interest in biotech start-ups has declined in recent years, which led Healthpeak to merge with Physicians Realty Trust, an owner of medical office buildings and senior housing properties, last year. Healthpeak lowered its dividend payout to account for all the extra shares it took on to merge with Physicians Realty. The stock price has fallen so far, though, that it offers a huge 6.5% yield at recent prices. Like Realty Income, it distributes dividend payments every month. Taking on medical office buildings could allow Healthpeak Properties to maintain its dividend payout, which is currently set at $1.22 annually. This year, the REIT expects adjusted FFO in a range between $1.81 and $1.87 per share. By 2030, all baby boomers will be at least 65 years old, and they're going to need a lot of medical attention. With heaps of medical office buildings and senior housing properties in its portfolio, Healthpeak is well positioned to ride this wave. Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Moody's and Realty Income. The Motley Fool recommends Healthpeak Properties. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 18:34
2mo ago
|
Nvidia Hits an All-Time High After Striking a Deal with OpenAI. Is the "Ten Titans" Growth Stock a Buy? | stocknewsapi |
NVDA
|
|
|
Nvidia will play a key role in the data centers that are powering OpenAI's models.
Nvidia (NVDA 0.27%) hit an all-time high on Sept. 22 in response to a $100 billion strategic partnership with OpenAI. Nvidia is helping OpenAI achieve its goal of building at least 10 gigawatts (GW) of data centers purpose-built for artificial intelligence (AI) by investing in data centers progressively as each GW is deployed. The news is significant, considering OpenAI needs funding to fulfill its promise, and because it is currently structured as a nonprofit (although it plans to become a Public Benefit Corporation). Nvidia is the most valuable company in the world and the largest of the "Ten Titans" -- which is the "Magnificent Seven" plus Broadcom (NASDAQ: AVGO), Oracle, and Netflix. The Ten Titans are highly influential -- making up nearly 40% of the S&P 500. Here's why Nvidia continues to be a powerhouse in the age of AI, where it stands amid competition from Broadcom, and whether it's worth buying now. Image source: Getty Images. Nvidia's deal with OpenAI As I've mentioned in the past, Nvidia is a steelmaker at the dawn of the age of skyscrapers. Nvidia makes the most advanced graphics processing units (GPUs) -- as well as associated networking components and software. These systems play an integral role in the parallel processing of AI workloads that require massive amounts of computing power. As OpenAI co-founder and CEO Sam Altman said in the Sept. 22 press release: Everything starts with compute. Compute infrastructure will be the basis for the economy of the future, and we will utilize what we're building with Nvidia to both create new AI breakthroughs and empower people and businesses with them at scale. Nvidia's investment in OpenAI builds on its $5 billion purchase of Intel stock, announced on Sept. 18. Intel will design and manufacture customer data center and central processing units (CPUs) with Nvidia's NVLink technology, which increases communication speed between GPUs and CPUs. Nvidia continues to push the bounds of AI computing power, and its results have been astounding, as its data center segment now makes up 88% of total revenue. Nvidia is growing earnings at a rapid pace with no signs of slowing down. But it isn't the only company that's driving the future of data center compute. Broadcom's custom AI chips are the real deal Broadcom's custom AI chips (XPUs) are application-specific integrated circuits (ASICs). Unlike GPUs, which are all-purpose workhorses in the data center, Broadcom works with hyperscalers to build custom AI chips to suit their AI workflows. The strategy is paying off, as Broadcom stock has outperformed Nvidia year-to-date -- hitting an all-time high and knocking on the door of a $2 trillion market cap. Like Nvidia, which depends on a handful of customers, Broadcom's AI revenue is largely tied to the ramp-up in hyperscaler capital expenditures. Broadcom's AI revenue is expected to reach nearly $20 billion by the end of this fiscal year, compared to $3.8 billion two years ago. So although Broadcom is still magnitudes smaller than Nvidia in terms of AI revenue, it is challenging Nvidia's dominance. Broadcom's AI chips, paired with its Jericho routers, Tomahawk switches, and other associated infrastructure, enable the connection of over 1 million XPU clusters across multiple data centers. At scale, Broadcom's custom chip economics improve dramatically because they are more energy efficient than general-purpose GPUs. Nvidia and Broadcom can win together Broadcom will likely play an increasingly important role in the data center, but it won't replace Nvidia. Rather, both companies will likely work together, with Broadcom specializing in task-specific functions and Nvidia leading in versatile compute for AI training, inference, and high-performance computing. The latest flurry of announcements showcases how both companies are positioned to thrive. In its latest earnings report from early September, Broadcom announced a $10 billion custom AI chip customer -- which is likely OpenAI. But OpenAI is also closely collaborating with Nvidia, serving as the key driver of its path to 10 GW in datacenter capacity. A hyperscaler like OpenAI may partner with Broadcom on custom AI chips for specific tasks, but these chips take a while to develop and are best for inference (handling the needs of existing AI models with fixed patterns). Whereas Nvidia's GPUs -- paired with its CUDA software system -- are a solution that works right now and is more flexible for variable and complex scenarios, like training models with new parameters. OpenAI is also likely reducing its dependence on one chip supplier, similar to how it has expanded its cloud partnership beyond Microsoft to include Oracle in a blockbuster $300 billion deal. Spreading business across multiple vendors reduces OpenAI's supply chain risk. Nvidia remains a top growth stock to buy now Nvidia remains the gold standard in the data center. It can thrive alongside Broadcom, so investors shouldn't view the two companies purely as competitors, but rather, as examples of the evolving anatomy of the modern AI data center. At 39.7 times forward earnings, Nvidia is far from cheap, but it also isn't as expensive as it used to be. Especially given that it is still growing earnings at a rapid rate. In fact, on a forward-earnings basis, Nvidia is cheaper than other Ten Titans stocks like Tesla, Broadcom, Netflix, and Oracle. And it's a much better buy for growth investors than a stock like Apple, which trades at 34.5 times forward earnings but is growing earnings far more slowly than Nvidia. All told, Nvidia remains a foundational AI growth stock to buy now. Although investors may want to consider incorporating both Nvidia and Broadcom into their long-term AI portfolios. Daniel Foelber has positions in Nvidia. The Motley Fool has positions in and recommends Apple, Intel, Microsoft, Netflix, Nvidia, and Tesla. The Motley Fool recommends Broadcom and recommends the following options: long January 2026 $395 calls on Microsoft, short January 2026 $405 calls on Microsoft, and short November 2025 $21 puts on Intel. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 18:34
2mo ago
|
3 Reliable High-Yield Dividend Stocks to Buy With $10,000 Now and Hold Forever | stocknewsapi |
BNS
O
TROW
|
|
|
If you are looking for dividend stocks with lofty yields and reliable payouts, these three companies should be on your short list.
The S&P 500 (SNPINDEX: ^GSPC) index has a tiny little average yield of around 1.2% today. That's probably not enough income to support most investors' retirement goals, particularly if they aim to rely largely on the distributions their portfolios churn out rather than on funds freed up by selling shares. If you're looking for high-yield investments, consider reliable dividend payers Realty Income (O 0.83%), T. Rowe Price (TROW 0.27%), and Bank of Nova Scotia (BNS 0.02%). 1. Realty Income's goal is reliability Realty Income has trademarked the nickname "The Monthly Dividend Company." That speaks not just to the unusual frequency of its payouts, but also to the company's commitment to being a reliable dividend payer. Management has increased those payouts annually for 30 consecutive years at this point. As a business, Realty Income is the 800-pound gorilla in the net lease niche of the real estate investment trust (REIT) sector. Its globally diversified portfolio is focused on retail properties, but also includes industrial assets. Because the company is so large (it owns more than 15,600 properties), its growth rate is slow. However, management has been working to find new areas to invest in; recently, it introduced an institutional asset management operation and made a push into the data center space. Realty Income isn't an exciting business and likely never will be, but given its lofty 5.3% dividend yield at current share prices, that probably won't bother most income investors. A $10,000 investment will buy you around 166 shares now. Image source: Getty Images. 2. T. Rowe Price has sticky customers With a strong foundation in the mutual fund arena, T. Rowe Price has an attractive asset-management business. Once customers have opened up an account with an asset manager, they are usually loath to go to the trouble of moving their money, which makes it a highly reliable business. That said, the asset-management business is changing as low-cost exchange-traded funds (ETFs) slowly eat away at the volume of assets held in mutual funds. T. Rowe Price's assets under management have been under pressure. It earns fees based on the amount of money it manages, so this is a long-term problem. However, T. Rowe Price is bringing out ETFs, and it's working to expand in areas where there is increasing demand, like private market investments. It just inked a partnership with Goldman Sachs to further that effort. And it will have plenty of time to adjust to the changing world around it, thanks to its sticky customer base and its debt-free balance sheet. T. Rowe Price stock carries a bit more risk than Realty Income, but its 4.9% dividend yield is good compensation for that risk. This asset manager has increased its dividend annually for 39 straight years. With $10,000, you can buy around 96 shares. 3. Bank of Nova Scotia has paid dividends for a long time Bank of Nova Scotia doesn't have a streak of annual dividend increases to crow about. (Indeed, technically, its "streak" is one whole year long). But it has a pretty impressive dividend history just the same: It has paid dividends every year since 1833. It is one of the largest financial institutions in Canada, and has material operations in South America, as well. Canadian banks are generally fairly conservative businesses thanks to the country's strict bank regulations. So it makes sense that Bank of Nova Scotia has been a reliable dividend stock. That said, it is in the middle of a material business overhaul right now, as it shifts its growth focus from South America back to North America. Essentially, it tried to skip over the U.S. market, but management has since come to realize that, despite the U.S. financial market being quite mature, it will likely provide more growth opportunities than the economically and politically volatile markets of South America. As it works on what is a fairly low-risk turnaround, thanks to its Canadian conservatism, you can collect a lofty 4.9% dividend yield. A $10,000 investment will let you buy around 155 shares. Long-term options for income investors Realty Income, T. Rowe Price, and Bank of Nova Scotia are fairly boring businesses, though the last two are, admittedly, dealing with some company-specific issues. All of these high yielders, however, have proven to be reliable dividend payers over many, many years. If you are looking for high-yield stocks you can comfortably buy and hold for the long term, you should consider them. Reuben Gregg Brewer has positions in Bank Of Nova Scotia and Realty Income. The Motley Fool has positions in and recommends Goldman Sachs Group, Realty Income, and T. Rowe Price Group. The Motley Fool recommends Bank Of Nova Scotia. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-28 23:06
2mo ago
|
2025-09-28 18:36
2mo ago
|
Prediction: 1 Artificial Intelligence (AI) Stock Will Be Worth More Than Nvidia and Palantir Combined by 2030 | stocknewsapi |
GOOG
GOOGL
|
|
|
Alphabet could become the largest company in the world in the next five years.
Alphabet (GOOG 0.21%) (GOOGL 0.28%) has become one of the world's most important artificial intelligence (AI) companies. What investors initially saw as a big potential risk has instead turned into a big tailwind. And while Nvidia and Palantir Technologies get plenty of the hype these days, Alphabet has the opportunity to be worth more than both of them combined before the decade is out. Nvidia currently sits at a $4.3 trillion market cap, while Palantir is around $425 billion. Alphabet is valued at roughly $3 trillion, but it has a real chance to grow significantly from here, while the other two face some risks. Alphabet's opportunities Alphabet's opportunities start with search and AI, which in some cases are melding into one. The company already owns the front door to the internet for billions of people, and most users don't even think about it because Google is just the default engine on most devices. Its ownership of the Chrome web browser and Android operating system, together with its revenue-sharing agreement with Apple, gives it a huge distribution advantage. AI, meanwhile, is not replacing search; it's enhancing it and complementing it. Alphabet says its AI Overviews are now being used by more than 2 billion people a month, and its new AI Mode, which is now just being rolled out globally, allows users to toggle between traditional results and chatbot-style answers without switching apps. It has also added multimodal AI features like Lens and Circle to search. These are just leading to more queries, often with a commercial intent from shoppers, which feeds into its massive ad network. This kind of seamless integration means the company doesn't need to rewire consumer habits the way competitors do; it only needs to make the products that people already use more useful. The fact that its Gemini app passed ChatGPT as the most downloaded app in the Apple App Store shows that the company is gaining real traction in AI on the consumer side. Image source: Getty Images Then there is Alphabet's biggest growth driver, its cloud computing business. The company is seeing both strong revenue growth and huge operating leverage as it scales up. This was seen last quarter when Google Cloud revenue jumped 32% and operating profit more than doubled. What sets Alphabet apart in cloud computing is that it owns the full stack, from its world-class Gemini AI model to custom AI chips, to top-notch analytics and software, to one of the largest private fiber networks in the world. That vertical integration means better performance at lower costs. The company's pending acquisition of Wiz will also give it a huge opportunity to cross-sell leading cloud cybersecurity to its customers. Investors should also remember Waymo, which could become one of its biggest growth drivers in the next five years. Robotaxis have been hyped for years, and with Waymo, Alphabet is currently building out a large fleet across the U.S. It has a first-mover advantage with commercial services running in several major U.S. cities, while being tested in others. If autonomous driving takes off in the next five years, Waymo could become another huge business. Meanwhile, Alphabet's stock is one of the cheapest among megacaps, at a forward price-to-earnings ratio (P/E) of less than 23 times 2026 analyst estimates. Between its growth opportunities and the potential for multiple expansion, the shares could have a lot of upside in the next five years. Palantir and Nvidia face risks Now contrast that with Palantir. It has been executing well, with its Artificial Intelligence Platform (AIP) in high demand from U.S. commercial customers, while it is continuing to win big government contracts. However, the stock's valuation is at nosebleed levels. With a forward price-to-sales multiple (P/S) of more than 100, the stock would still be expensive even if it that figure were cut in half. This is a valuation that leaves no margin for error; one slipup on growth, and the stock will get punished. And then there is Nvidia. Undoubtedly, it has been the biggest winner in the AI boom, but investors should not forget it is still a hardware company. Hardware sales are not recurring revenue, since every chip sold has to be replaced by the next cycle of spending, and once customers find a cheaper or more efficient solution, the shift can happen fast. We've seen this happen before. The company's graphics processing units (GPUs) were once the primary chips used in Bitcoin mining until ASICs (application-specific integrated circuits) that did the job faster and cheaper came along. Practically overnight, mining Bitcoin with GPUs became irrelevant. While ASICs aren't likely to completely replace GPUs for AI workloads, they are a rising threat, especially as the market moves more toward inference, which is a continuous cost -- and hyperscalers (companies that own large data centers) are highly motivated to lower computing costs. With inference not nearly as technically demanding as training, Nvidia's CUDA software moat is not as wide in this area, and more and more large companies have started developing their own custom AI chips. Nvidia knows this, which is why its recently-announced $100 billion OpenAI partnership looks more defensive than offensive. OpenAI is one of Nvidia's biggest customers, but it has also been developing its own chips. With this investment, Nvidia is effectively paying to keep OpenAI tied to its GPUs, which is a risky kind of circular financing that echoes what Cisco did during the internet bubble. Nvidia's dominance in AI infrastructure today is unquestioned, but the upside in the stock could be limited if customers keep moving toward in-house AI chips. Put it all together, and Alphabet looks like the company best positioned to become the largest in the world by 2030, with a good chance of being bigger than both Nvidia and Palantir combined. Geoffrey Seiler has positions in Alphabet. The Motley Fool has positions in and recommends Alphabet, Apple, Bitcoin, Cisco Systems, Nvidia, and Palantir Technologies. The Motley Fool has a disclosure policy. |
|||||
|
2025-09-28 22:06
2mo ago
|
2025-09-28 16:00
2mo ago
|
Bitcoin Long-Term Holders Easing Off On Sales—What's Happening? | cryptonews |
BTC
|
|
|
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure
The past week was one of intense volatility for the crypto market, as the Bitcoin price experienced a sharp nosedive from as high as $116,000 to a swing low of about $108,600. While this recent decline has led to worries about the start of a bearish rally, recent on-chain data suggests that the market may be reaching a state of calm. LTHs’ Selling Pace On The Decline In a recent post on social media platform X, Alphractal revealed what may be good news for Bitcoin’s bullish onlookers. According to the on-chain analytics firm, there seems to be a shift in the behavior of the premier cryptocurrency’s long-term holders (LTH). This on-chain revelation is based on the Coin Days Destroyed (CDD) Multiple Metric, which measures the intensity of coin spending in relation to historical averages. As explained by the firm, the metric calculates how many “coin days” are destroyed when old coins are moved. In other words, it looks at when long-term holders decide to spend their coins, thereby tracking a shift in the Bitcoin LTH activity. Source: @Alphractal on X As pointed out by Alphractal, members of this investor class have continued to move their old coins, but the pace of their sales has dropped significantly. Compared to 2024, the movement of Bitcoin long-term holders in the market has been slow over the past few months. Ultimately, this dip in CDD Multiple also signals reduced selling pressure from Bitcoin’s seasoned investors. What This Means For Price As of this writing, Bitcoin is trading within a volatile market just above the week’s swing low of $108,500. However, the experienced investors seem not to be in a rush to sell off their holdings. Instead of continuing to sell, the long-term holders seem to have started preserving their coins again. “This decline in coin day destruction activity suggests that many experienced investors are choosing to hold their positions, waiting for stronger market moves,” the analytics firm said. Historically, this type of behavior among the cryptocurrency’s earliest holders has preceded periods of accumulation, where the confidence of these investors offers stability in the market, preventing further decline in price. If history is anything to go by, the reduced CDD Multiple could be a sign that the groundwork for Bitcoin’s next big expansion is being laid. Moves around the last swing low should therefore be watched closely, alongside CDD activity, before investment decisions are made. At the time of writing, Bitcoin is worth about $109,630, reflecting no significant movement in the past 24 hours. The price of BTC on the daily timeframe | Source: BTCUSDT chart on TradingView Featured image from iStock, chart from TradingView Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers. Sign Up for Our Newsletter! For updates and exclusive offers enter your email. Opeyemi Sule is a passionate crypto enthusiast, a proficient content writer, and a journalist at Bitcoinist. Opeyemi creates unique pieces unraveling the complexities of blockchain technology and sharing insights on the latest trends in the world of cryptocurrencies. Opeyemi enjoys reading poetry, chatting about politics, and listening to music, in addition to his strong interest in cryptocurrency. |
|||||
|
2025-09-28 22:06
2mo ago
|
2025-09-28 16:34
2mo ago
|
Bitcoin and Ethereum ETFs Lose $1.7 Billion as Institutions Retreat | cryptonews |
BTC
ETH
|
|
|
Spot Bitcoin and Ethereum ETFs in the US saw a sharp reversal last week, shedding more than $1.7 billion after weeks of steady inflows.The downturn, driven by inflation concerns, slowing growth, and monetary policy uncertainty, pushed institutions to cut exposure to high-risk assets.At the same time, capital is rotating into new ETFs tied to Solana and XRP, signaling a shift toward selective diversification.Spot Bitcoin and Ethereum exchange-traded funds (ETFs) in the United States reversed course sharply last week, shedding more than $1.7 billion.
This shift came amid Bitcoin and Ethereum price volatility during the past week as both assets shed more than 8% during the reporting period. Sponsored Sponsored Bitcoin and Ethereum ETFs Bleed Cash Amid Market Volatility According to data from SoSoValue, spot Bitcoin ETFs recorded $903 million in net withdrawals. The outflows ended a month-long streak of inflows that had reflected growing institutional confidence. That sentiment shifted as macroeconomic uncertainty deepened, prompting many institutional investors to trim exposure and adopt a defensive stance. Ethereum products mirrored the downturn but endured even heavier losses. Ethereum ETFs Net Daily Inflow This Week. Source: SoSoValue Data from SoSoValue shows that the nine US-listed spot Ethereum ETFs saw redemptions, amounting to $796 million in outflows. This is their largest weekly withdrawal since launching earlier this year. The synchronized retreat across both assets reflects a broader cooling in crypto ETF demand. Sponsored Sponsored Institutional allocators once viewed these vehicles as a convenient entry point into digital assets. They are now reassessing their strategies in light of growing macro headwinds. Over the past week, persistent inflation concerns, slowing global growth, and heightened uncertainty around US monetary policy have reduced appetite for volatile assets. In this environment, digital assets—long categorized as high risk—were among the first to be pared from portfolios. Meanwhile, institutional strategies have also grown more defensive, especially as investors are increasingly being exposed to losses. CryptoQuant data shows that Bitcoin treasury firms raising capital through PIPE deals are under pressure, as share prices trend toward discounted issuance levels. At the same time, investor attention is rotating toward newly launched ETFs tied to alternative tokens like Solana and XRP. These vehicles have drawn capital away from Bitcoin and Ethereum funds, introducing fresh competition and encouraging experimentation with underrepresented assets. The redirection of inflows suggests that while risk sentiment has cooled, appetite for diversification within crypto remains active — just more selective and opportunistic than before. Disclaimer In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated. |
|||||
|
2025-09-28 22:06
2mo ago
|
2025-09-28 17:24
2mo ago
|
Bitcoin, XRP i nowa fala adopcji kryptowalut. Co przyniesie ostatni kwartał 2025 roku? | cryptonews |
BTC
XRP
|
|
|
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure
Rynek kryptowalut wchodzi w ostatni kwartał 2025 roku z dużą dynamiką. Decyzje amerykańskich regulatorów, rosnące zainteresowanie funduszy ETF oraz nowe projekty technologiczne sprawiają, że inwestorzy zastanawiają się, jak ulokować swoje środki. Nie chodzi już tylko o Bitcoina czy Ethereum. Dziś na radarze pojawiają się zarówno dojrzałe aktywa, jak XRP, jak i świeże inicjatywy w rodzaju Snorter Token. Nadchodzi nowa fala adopcji kryptowalut. XRP kandydatem do trzeciego miejsca na podium ETF-ów Ostatnie tygodnie przyniosły istotne informacje dla rynku. SEC analizuje sześć wniosków o uruchomienie spot ETF-ów powiązanych z XRP. Wśród aplikujących są takie podmioty jak Grayscale, 21Shares czy WisdomTree. Decyzje mają zapaść między 18 a 25 października. 🚨 XRP SPOT ETF TRACKER 🚨 📅 OCTOBER WILL BE HISTORIC: 🔹 Grayscale — OCT 18 🔹 21Shares — OCT 19 🔹 Bitwise — OCT 20 🔹 Canary Capital — OCT 23 🔹 WisdomTree — OCT 24 🔹 Franklin Templeton — OCT 25 🔹 CoinShares — OCT 25 🔥 $XRP Are you ready? 🤔 pic.twitter.com/PrNW0GevU4 — John Squire (@TheCryptoSquire) September 26, 2025 Analitycy wskazują, że ewentualna zgoda oznaczałaby otwarcie drzwi dla ogromnego kapitału instytucjonalnego. Cytując jednego z ekspertów: Zatwierdzenie ETF-ów na XRP może uruchomić rotację płynności z Bitcoina i skierować uwagę funduszy na trzecią co do wielkości kryptowalutę pod względem adopcji regulacyjnej. Warto zauważyć, że Bitcoin już korzysta z efektu ETF-ów, a Ethereum powoli podąża jego śladem. Jeśli XRP dołączy do tego grona, układ sił na rynku może się zmienić. Derywatywy budują fundamenty pod dalszy wzrost Nie tylko ETF-y napędzają oczekiwania wobec XRP. Coraz większą rolę odgrywa rynek instrumentów pochodnych. Dane CME pokazują, że otwarte pozycje na kontraktach futures na XRP przekroczyły 1 miliard dolarów, co jest najszybszym wzrostem wśród wszystkich kryptowalut w tym kwartale. CME ogłosiło także, że od 13 października uruchomi opcje na XRP oraz kontrakty Micro XRP. Dzięki temu inwestorzy instytucjonalni otrzymają regulowane narzędzia do ekspozycji na XRP – komentują analitycy. Równolegle Ripple stara się o licencję bankową w USA, która w przypadku powodzenia zapewni jej bezpośredni dostęp do systemu bankowego. To ruch, który zwiększyłby wiarygodność projektu w oczach największych inwestorów. XRP w kluczowym punkcie Z technicznego punktu widzenia XRP znajduje się w formacji trójkąta zniżkującego. Dolne wsparcie w rejonie 2,70 USD pozostaje nieprzełamane, ale każdy test tego poziomu budzi nerwowość. Średnia krocząca 50-dniowa na poziomie 2,96 USD zatrzymuje kolejne próby wybicia w górę. Źrodło: TradingView Świece z długimi cieniami pokazują walkę podaży z popytem, a RSI w okolicach 40 sugeruje brak wyraźnego momentum. Scenariusze są jasne: byki mogą przejąć inicjatywę dopiero po zamknięciu dnia powyżej 3,00 USD, niedźwiedzie liczą na spadek w okolice 2,59 USD. Rynek czeka więc na katalizator, a takim może być październikowa decyzja SEC. Snorter Token – nowe narzędzie na Solanie Podczas gdy XRP walczy o regulacyjną legitymizację, na drugim końcu spektrum pojawiają się projekty świeże i innowacyjne. Jednym z nich jest Snorter Token. Jest on botem tradingowym działającym w ekosystemie Solany. Jego presale zebrał już ponad 4 miliony dolarów, a do zakończenia sprzedaży pozostało jedynie 25 dni. Aktualna cena wynosi 0,1063 USD. W świecie, gdzie inwestorzy nieustannie poszukują kryptowalut z potencjałem x1000, Snorter wzbudza zainteresowanie dzięki połączeniu technologii i marketingu. Dlaczego Solana? Szybkość i niskie koszty Snorter został oparty na Solanie, ponieważ sieć ta zapewnia błyskawiczne transakcje i minimalne prowizje. To kluczowa przewaga nad botami działającymi na Ethereum, które często zmagają się z wysokimi opłatami i przeciążeniami sieci. Główna funkcja Snortera to wykrywanie nowych tokenów jeszcze zanim staną się popularne. Bot monitoruje mempoole zarówno Solany, jak i Ethereum, wychwytując świeże projekty i pierwsze oznaki płynności. Dzięki temu użytkownicy mogą wchodzić w rynek szybciej niż reszta inwestorów. Bezpieczeństwo przede wszystkim Twórcy Snortera podkreślają, że nie chodzi o ślepe polowanie na każdy nowy token. Wbudowane filtry kontraktów i mechanizmy anty-rug mają minimalizować ryzyko związane z oszustwami czy tzw. rug pullami. Warto przypomnieć, że wielu inwestorów, którzy w 2021 roku kupowali Dogecoina czy Shiba Inu na szczytach, do dziś pozostaje na stratach. Snorter ma działać odwrotnie. Ma na celu umożliwiać wejście w projekt na wczesnym etapie i wyjście z zyskiem, gdy szerszy rynek dopiero się dowiaduje o jego istnieniu. Token SNORT – serce ekosystemu Posiadanie tokena SNORT odblokowuje pełnię możliwości bota. Najważniejsze korzyści to: obniżona prowizja za handel do 0,85% (konkurencja często pobiera 1,5–2%), unlimited snipes – możliwość uczestnictwa w dowolnej liczbie projektów, dostęp do zaawansowanych analiz, udział w głosowaniach nad rozwojem projektu, staking z dynamicznym APY sięgającym 115%. Każdy z tych elementów zwiększa popyt na token i jednocześnie ogranicza jego podaż w obiegu. Śpiesz się, presale jest na finiszu Presale Snortera kończy się za 21 dni. Po tym terminie token trafi na giełdy, gdzie jego cena prawdopodobnie wzrośnie wraz z popytem. Inwestorzy mają ograniczone okno czasowe, aby wejść na preferencyjnych warunkach. Zakupu można dokonać za pomocą SOL, ETH, BNB, USDT, USDC, a także kartą kredytową. Rekomendowanym rozwiązaniem jest portfel Best Wallet. W praktyce odpowiedź na pytanie jak kupić Snorter Token sprowadza się więc do kilku kliknięć. Kryptowaluty łączą technologię i kulturę Przypadek Snortera pokazuje szerszy trend. Kryptowaluty coraz częściej łączą dwa światy, czyli zaawansowaną technologię i społecznościowy marketing. To połączenie może sprawić, że projekt zyska finalny sukces poprzez kompleksowe podjeście. W tym sensie Snorter staje się ciekawym uzupełnieniem dynamicznej sceny kryptowalut, w której z jednej strony instytucje czekają na decyzje SEC w sprawie XRP, a z drugiej inwestorzy indywidualni polują na kolejne okazje. Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers. |
|||||
|
2025-09-28 22:06
2mo ago
|
2025-09-28 17:28
2mo ago
|
AI Predicts If Cardano Network Upgrades Can Push ADA Price Past $3 By 2027 | cryptonews |
ADA
|
|
|
Project Acropolis could support ADA closer to $1 if it delivers smoother upgrades and stability, though downside risk remains near $0.70.Hydra adoption may lift ADA toward the $1.50 zone if flagship dApps integrate it successfully; limited uptake would keep prices below $1.Ouroboros Leios has potential to re-rate ADA above $2 if testnet results prove strong, creating conditions for a $3 target by 2027.Cardano’s upcoming upgrades could define whether its native token ADA breaks a multi-year ceiling. With Project Acropolis, Hydra adoption, and Ouroboros Leios ahead, the question is whether these technical milestones can reset Cardano’s market narrative and push ADA toward $3 by 2027.
This predictive analysis was conducted through AI using sequence prompting, learning, and advanced reasoning. It should not be taken as financial advice. Readers should perform their own research and consider professional guidance before making investment decisions. Most importantly, this predictive analysis doesn’t consider additional developments such as institutional adoption, ETF approvals, or regulatory decisions. It’s solely pivoted on Cardano network upgrades and their impact on ADA. Cardano Network Upgrade Timeline and Expected Impact UpgradeTimingTechnical focusWhy it matters for priceExpected ADA price range*Project AcropolisQ4 2025 – Q1 2026Modular node re-architectureImproves stability and shipping cadence; lowers execution risk$0.70 – $0.95Hydra adoption2026 (ongoing)L2 “heads” for low-latency settlementDelivers faster, cheaper UX if apps integrate$0.90 – $1.40Ouroboros LeiosMid–late 2026 (testnet first)Parallelism at base layerRe-rates capacity and long-term utility if metrics hold$1.30 – $2.20Post-Leios path to Mega2027+Advanced scaling roadmapCompounds if delivery stays consistent$2.00 – $3.50 *Ranges reflect tech-to-adoption pathways, not market timing calls. Sponsored Sponsored How Cardano Upgrades Translate To ADA Price Markets reward credible execution and user impact. Three channels matter: Throughput and UX → activity and TVL narrative: Faster, cheaper, smoother apps attract users and volume. Developer velocity → shorter time-to-feature: Modular code and stable tooling speed delivery. That reduces the “execution discount.” Transparency and governance discipline: Clear milestones and reporting lower perceived risk. Price moves when those channels show verifiable proof, not promises. Project Acropolis: Credibility and Velocity Uplift Why this can move ADA price toward $0.90–$0.95 Acropolis modularizes the node and reduces operational friction. That makes maintenance easier and future features faster to ship. Stake pool operators should see lower resource strain and fewer regressions. Release cadence should improve. Markets price this as a lower execution risk premium. If monthly releases arrive cleanly, confidence rises. That supports a re-rating into the $0.90 area. Downside remains $0.70 risk If Acropolis slips or spawns hotfix churn, the execution discount returns. SPO frustration or reliability incidents would cap sentiment. Price gravitates toward $0.70 until stability improves. Proof to watch Sponsored Sponsored Smooth minor releases for several months. Positive SPO feedback on performance and uptime. More merged PRs and contributor breadth. Hydra: Adoption-Driven Valuation, Not Version Bumps Why this can move ADA toward $1.20–$1.40 Hydra only matters when top dApps integrate it and publish before/after metrics. Users must experience material latency and cost gains. That lifts activity and strengthens Cardano’s competitive UX story. Named integrations create a visible moat. One flagship success can push ADA through $1.20. Several production heads with public metrics can sustain $1.30–$1.40. But it can stall under $1. If Hydra stays niche or tooling remains complex, users see no change. Markets fade the hype and keep ADA range-bound. Proof to watch Production Hydra heads with regular settlement. Public case studies from major dApps. Wallet and SDK support that hides Hydra complexity. Sponsored Sponsored Ouroboros Leios: The Base-Layer Scaling Catalyst Why this can move ADA toward $1.30–$2.20 Leios separates proposal and validation to introduce parallelism. Strong, reproducible testnet metrics signal a credible path to higher base-layer capacity. That expands the feasible app set and reduces future congestion risk. Markets reward capacity plus decentralization. A stable Leios testnet reframes Cardano’s throughput story. ADA can re-rate toward $2 if the evidence holds. Conversely, it could cap near $1.20. If metrics wobble or rollout drags, the scaling story weakens. Without clear gains, capital rotates to faster-shipping ecosystems. Proof to watch Clear testnet milestones with published performance. Compatibility notes that ease dApp migration. Operator feedback on security and stability. Post-Leios To $3+Sponsored Sponsored Why this can stretch ADA to $2.00–$3.50 by 2027 The path above $3 requires compounding: Acropolis sustains faster shipping and fewer incidents. Hydra powers several marquee apps with public wins. Leios transitions from testnet to staged mainnet usage without regressions. Tooling makes advanced features invisible to users. That combination reduces risk, boosts activity, and attracts builders. Markets then price a durable execution premium. The result supports a $2–$3.50 band. However, security incidents, missed milestones, or weak app traction will compress multiples. Narrative slips, and ADA trades with beta rather than a premium. Critical Outlook Each upgrade builds on the last. Acropolis enables faster shipping, Hydra requires adoption, and Leios brings the base-layer scaling narrative. Mega remains an aspirational horizon. For ADA to cross $3, Cardano must convert research depth into visible user impact. Investors should watch for proof in live dApps, validator feedback, and transparent reporting. Overall, execution, not promises, will determine if Cardano reclaims a premium in the Layer-1 market. Disclaimer In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated. |
|||||
|
2025-09-28 22:06
2mo ago
|
2025-09-28 17:30
2mo ago
|
XRP Futures Blaze Past $18.3B as CME Achieves 4-Month Milestone | cryptonews |
XRP
|
|
|
XRP futures are gaining unstoppable institutional traction as CME Group smashes volume records and prepares to unleash new options on solana and XRP, signaling surging demand for regulated crypto exposure. XRP Futures Deliver $18.
|
|||||
|
2025-09-28 22:06
2mo ago
|
2025-09-28 17:36
2mo ago
|
Cardano's $1.90 Target: How Cross-Chain Partnerships and DeFi Innovation Are Driving ADA's Growth | cryptonews |
ADA
|
|
|
Cardano (ADA) is steadily positioning itself as a key player in the evolving crypto market, with its 2025 roadmap signaling strong growth potential. The cryptocurrency's potential surge to $1.90 is being fueled by a combination of cross-chain partnerships, DeFi innovation, whale accumulation, and strategic market moves.
|
|||||
|
2025-09-28 22:06
2mo ago
|
2025-09-28 18:00
2mo ago
|
Ethereum Open Interest Sees Sharpest Reset Since 2024 As Price Drops Below $4,000 | cryptonews |
ETH
|
|
|
Ethereum is undergoing one of the most significant resets in over a year, caused by its price breaking below $4,000. This retest has been most visible in futures open interest, where billions of dollars in positions have been wiped out across major exchanges. This rapid unwinding comes as a correction move to weeks of excessive leverage during uptrends that had pushed derivatives activity to unsustainable levels.
Massive Open Interest Wipeout Across Major Exchanges The most recent Ethereum price correction was a broader market reset rather than a mere dip, with leveraged traders facing the brunt of the losses. Data shows that Ethereum’s open interest experienced a steep downfall over the just concluded week across multiple crypto exchanges. According to data from on-chain analytics platform CryptoQuant, billions worth of Ethereum positions were wiped out last week, with Binance leading the downturn with the steepest monthly average drop. Ethereum’s slide under the $4,000 mark proved to be the breaking point for over-leveraged traders. The move unleashed a wave of liquidations across derivatives markets, compounding selling pressure. Data shows that more than $3 billion was erased on September 23 through Binance alone, followed by over $1 billion just a day later. Bybit also shed $1.2 billion in positions, while OKX recorded a $580 million decline. The sharp reduction is visible in aggregate open interest, which has slumped to its lowest level since early 2024. As the chart data shows, futures leverage and open interest were closely tied to the price rally in July and August, and at the same time, it declined in lockstep with the price. Ethereum Open Interest by exchange Spot Ethereum ETF Outflows Add To Market Strain Ethereum’s break below $4,000 and the decline in open interest coincides with a week of heavy outflows from spot Ethereum ETFs in the United States. According to data from Farside Investors, $795.56 million flowed out over five trading days last week, which is the largest weekly exodus since the products launched. ETHUSD now trading at $3,996. Chart: TradingView The sell-off intensified toward the end of the week, with Thursday recording $251.2 million in outflows, followed by another $248.4 million on Friday. Waning institutinal participation contributed massively to the sell-side pressure, with investors showing caution amid uncertainty over whether regulators will allow staking features in these ETFs. This synchronized exit from both derivatives and institutional products has amplified volatility, creating a convergence of pressure across Ethereum’s trading ecosystem. After dipping as low as $3,845, ETH bulls have managed to hold above $3,800. At the time of writing, Ethereum is trading at $4,002. Despite this attempt to regain stability, the leading altcoin is still down by about 10% in a weekly timeframe, considering it was trading around $4,490 this time last week. The bullish scenario now lies in whether ETH can reclaim and sustain a move above $4,000. Featured image from Unsplash, chart from TradingView |
|||||
|
2025-09-28 21:06
2mo ago
|
2025-09-28 16:06
2mo ago
|
Three Reasons ASTER Price Is Sliding Despite CZ's Backing | cryptonews |
ASTER
|
|
|
Aster token slides 20% from September peak as traders question platform speed, polish, and long-term competitiveness against rivals.Investor exits and mixed signals from CZ add fuel to doubts, sparking skepticism despite early adoption and Binance-linked support.Fundamentals remain strong with $70 million in fees and $701 million TVL, but user trust and competition with Hyperliquid weigh on sentiment.Aster, a decentralized perpetuals exchange launched in early September, has experienced a 10% drop in the last 24 hours alone.
Despite strong early traction and backing from Binance founder Changpeng Zhao (CZ), cracks in sentiment are beginning to show. Analyst Explains Why Aster Price is DroppingSponsored Sponsored As of this writing, Aster’s powering token, ASTER, was trading for $1.87, down 8% in the last 24 hours. The token is down over 20% from its local top of $2.43, established on September 24. Aster (ASTER) Price Performance. Source: TradingView Against this backdrop, analysts have dissected what could be driving the price drop of the decentralized exchange (DEX) token. Price Pressure and User Doubts The sell-off comes amid growing skepticism around Aster’s platform performance. Investor Mike Ess revealed on X (Twitter) that he sold 60% of his Aster holdings, rotating into Bitcoin (BTC) and Plasma (XPL). While he remains profitable, he said his decision was driven by gut instinct after Changpeng Zhao’s recent comments and dissatisfaction with Aster’s product. “If you’ve used HYPE, then switched to Aster, you know exactly what I mean. It feels slower, less polished, and copy-paste… The more capital I have on it, the riskier it feels,” wrote Ess. Sponsored Sponsored Other traders have echoed similar concerns. Clemente, another renowned voice on X, disclosed that he exited his Aster position entirely in favor of Hyperliquid’s HYPE token. “Hyperliquid is clearly the leader in every metric other than crime and CEX distribution,” the analyst argued. Mixed Signals From CZ CZ’s involvement has been a double-edged sword. On September 28, the crypto executive framed Aster as a complementary project to the broader BNB Chain ecosystem despite rivaling the Binance exchange. Sponsored Sponsored His venture firm, YZi Labs (formerly Binance Labs), holds a minority stake in Aster, which also boasts a team of former Binance employees. However, traders like Ess interpreted CZ’s tone on a recent Spaces call as distancing, raising doubts about his level of engagement. For some, this perception was enough to spark de-risking. “If CZ stops talking about it, HYPE wins hands down,” Ess warned. Still, bullish voices remain. A user known as Cooker expressed conviction that Aster will make a long-term mark on the perp DEX market. Still holding onto $ASTER, truly banking on CZ and their team to make their long term mark on the perp dex market Holding $XPL long term will prob be one of the best holds since $HYPE going into 2026 Ofc still holding $HYPE, soon to be a year long hold from my original buy — Cooker.hl | Kms.eth | Cooker (@CookerFlips) September 28, 2025 Meanwhile, others, like Crash, argued that Aster could outperform Solana and Ethereum in percentage terms over the next cycle. Sponsored Sponsored Strong Fundamentals, Lingering Uncertainty By several measures, Aster’s fundamentals remain solid. Since launch, the platform has generated $70 million in fees, while total value locked (TVL) has ascended to $701 million on BNB Chain. For a project only weeks old, these numbers reflect significant adoption. Aster on BNB Chain. Source: DefiLlama Yet the quick drawdown highlights the challenge of balancing early growth with user trust and product reliability. Analysts warn that competition with Hyperliquid is intensifying, and without continued product improvement, momentum could fade. Therefore, the Aster price’s trajectory remains contested, with supporters seeing it as a bold new player with CZ’s stamp of approval amid a fast-paced scaling ecosystem. On the other hand, skeptics say Aster may be unfinished and overhyped. Disclaimer In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated. |
|||||